JPH0240055B2 - Ranjitsukuashitsudojudotai - Google Patents
RanjitsukuashitsudojudotaiInfo
- Publication number
- JPH0240055B2 JPH0240055B2 JP21204285A JP21204285A JPH0240055B2 JP H0240055 B2 JPH0240055 B2 JP H0240055B2 JP 21204285 A JP21204285 A JP 21204285A JP 21204285 A JP21204285 A JP 21204285A JP H0240055 B2 JPH0240055 B2 JP H0240055B2
- Authority
- JP
- Japan
- Prior art keywords
- ester
- acid
- compound
- group
- derivative according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 claims description 58
- 150000001875 compounds Chemical class 0.000 claims description 34
- 150000002148 esters Chemical class 0.000 claims description 24
- -1 hydroxyacid monoethyl ester Chemical class 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 231100000252 nontoxic Toxicity 0.000 claims description 7
- 230000003000 nontoxic effect Effects 0.000 claims description 7
- 125000003277 amino group Chemical group 0.000 claims description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 claims description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- ITAMCOCNZJPJDF-UHFFFAOYSA-N 1-(6-aminopurin-9-yl)propan-2-yloxymethyl-phenoxyphosphinic acid Chemical compound C1=NC2=C(N)N=CN=C2N1CC(C)OCP(O)(=O)OC1=CC=CC=C1 ITAMCOCNZJPJDF-UHFFFAOYSA-N 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 2
- 150000001261 hydroxy acids Chemical class 0.000 claims 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 28
- 239000000203 mixture Substances 0.000 description 27
- 238000000034 method Methods 0.000 description 26
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 14
- 229960003473 androstanolone Drugs 0.000 description 14
- 238000004809 thin layer chromatography Methods 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- 206010000496 acne Diseases 0.000 description 11
- 208000002874 Acne Vulgaris Diseases 0.000 description 10
- 201000004384 Alopecia Diseases 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 150000001408 amides Chemical class 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 7
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 7
- 150000004820 halides Chemical class 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000008065 acid anhydrides Chemical class 0.000 description 6
- 238000005886 esterification reaction Methods 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 229960003604 testosterone Drugs 0.000 description 6
- 231100000360 alopecia Toxicity 0.000 description 5
- 206010068168 androgenetic alopecia Diseases 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003701 inert diluent Substances 0.000 description 5
- 230000000704 physical effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 238000007112 amidation reaction Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 201000002996 androgenic alopecia Diseases 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000012457 nonaqueous media Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- MUMGGOZAMZWBJJ-WLRIMQDWSA-N (8r,9s,10r,13s,14s,17s)-10,13-dimethyl-17-oxidanyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=[14CH]1 MUMGGOZAMZWBJJ-WLRIMQDWSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- YZBOVSFWWNVKRJ-UHFFFAOYSA-M 2-butoxycarbonylbenzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1C([O-])=O YZBOVSFWWNVKRJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical class [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 230000002862 amidating effect Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940095074 cyclic amp Drugs 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical class NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000004656 dimethylamines Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920003117 medium viscosity grade hydroxypropyl cellulose Polymers 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- DVQHRBFGRZHMSR-UHFFFAOYSA-N sodium methyl 2,2-dimethyl-4,6-dioxo-5-(N-prop-2-enoxy-C-propylcarbonimidoyl)cyclohexane-1-carboxylate Chemical compound [Na+].C=CCON=C(CCC)[C-]1C(=O)CC(C)(C)C(C(=O)OC)C1=O DVQHRBFGRZHMSR-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯ãã©ã³ãžãã¯ã¢ã·ããã®æ°èŠãªãšã¹ã
ã«åã³ã¢ããã«é¢ããã ãçºæã®èæ¯ã åŸæ¥ãããç·æ§åè±æ¯çã®æå ãšããŠã¯ã(1)ã
ã«ã¢ã³ã®ã¢ã³ãã©ã³ã¹èª¬ã(2)éºäŒèª¬ã(3)è¡æ¶²åŸªç°
äžå šèª¬ã(4)æ é€èª¬çæ°å€ãã®èª¬ãæå±ãããŠãã
ããæ¯ã®çºçã«ç·æ§ãã«ã¢ã³ã®ãã¹ãã¹ããã³
ïŒtestosteroneïŒãéèŠãªåœ¹å²ãæŒããŠããããš
ã¯å€ããã瀺åãããŠããããã¹ãã¹ããã³ãšç·
æ§åè±æ¯çã®å æé¢ä¿ãå®éšçã«çååŠã®ã¬ãã«
ã§èšŒæããå®éãã®èª¬ïŒBiochem.Biophys.Res.
Commun.ïŒ41ïŒ884ïŒ1970ïŒåç §ã®ããšãã«ãã
ãšãçŸäžžã§çåæããããã¹ãã¹ããã³ã¯é éšã«
ãããŠãæ¯å ãè¥èç·çã«ååšãã5αâãªãã¯
ã¿ãŒãŒïŒ5αâreductaseïŒã«ãããžããããã¹ã
ã¹ããã³ïŒDihydoroteststeroneïŒã«å€æããã
ãã®ãžããããã¹ãã¹ããã³ãã¢ããã«ãµã€ã¯ã©
ãŒãŒïŒadenyl cyclaseïŒã®æŽ»æ§ãèããäœäžãã
ãããšã«ãã现èå ã®ãµã€ã¯ãªãã¯âAMPã¬ã
ã«ã®äœäžãããããããã®çµææ¯åã³æ¯ã®åšèŸºã®
ãšãã«ã®ãŒç£çã®äœäžãšã¿ã³ãã¯è³ªåæã®æå¶ã
èªèµ·ãããåã€ãŠããããäžé£ã®çŸè±¡ã«ãããæ
é·æã«ããæ¯ã¯äŒæ¢æã«ç§»è¡ãããã®ç¶æ ããã
è¿ããŠããéã«çµæ¯ããè»æ¯ãžããããŠæçµçã«
ã¯ç·æ§åãã²ã«ãŸã§é²è¡ãããšèããããããã®
説ãè£ä»ãããã®ãšããŠãã·ãŠãã€ã±ã«ããH.
V.Schweikertããã¯ãç·æ§åãã²ã®æ¯å ã«ã¯ã
女æ§ã®æ¯å ããã²ã§ãªã人ã®æ¯å ã«æ¯ããŠã5α
âãªãã¯ã¿ãŒãŒã«ãã代è¬ç©ãããªãã¡ãžããã
ãã¹ãã¹ããã³çãå€éã«ååšããŠããããšãå ±
åããŠãããJ.Clin.Endocr.ïŒ38ïŒ811ïŒ1974ïŒå
ç §ã®ããšãã ç·æ§åè±æ¯ç以å€ã«ãããã¹ãã¹ããã³ãã
5αâãªãã¯ã¿ãŒãŒã«ããçæãããžããããã¹
ãã¹ããã³ã¯ãã¢ã¯ãïŒãç¡ããããçïŒã®çº
çãå¢æªã«ãéèŠãªççç圹å²ãæŒããŠããããš
ãå ±åãããŠãããããªãã¡ãJ.B.Hayãã¯ã¢ã¯
ãæ£éšã«ãããæ£éšã®ç®èãšæ£åžžç®èã§ã®ãã¹ã
ã¹ããã³ã®ä»£è¬é床ãæ¯èŒãããšããããã¹ãã¹
ããã³ã®5αâãªãã¯ã¿ãŒãŒã«ãã代è¬ã¯ã¢ã¯ã
æ£éšã«ãããŠäº¢é²ããŠããããšãå ±åããŠãã
ãBr.J.Dermatol.ïŒ91ïŒ123ïŒ1974ïŒãããŸãG.
Sansoneãã¯ã¢ã¯ãæ£è ã®æ£éšç®èäžã®ãã¹ãã¹
ããã³ãããžããããã¹ãã¹ããã³ãžã®åæèœ
ã¯ãæ£åžžäººã®ããã®ïŒã20åç°åžžäº¢é²ããŠããã
ãšãèŠãåºããã¢ã¯ãã®çºçãå¢æªã«å¯ŸããŠ5α
âãªãã¯ã¿ãŒãŒã«ããçæãããžããããã¹ãã¹
ããã³ã倧ããé¢äžããŠããããšã瀺åããŠãã
ãJ.Invest.Dermatol.ïŒ56ïŒ366ïŒ1971ïŒãã ããã«ããžããããã¹ãã¹ããã³ã¯åç«è ºã®è¥
倧ã«ãé¢äžããŠãããCowanãã¯åç«è ºè¥å€§ç
æ£è ã®åç«è ºäžã«ã¯ãžããããã¹ãã¹ããã³ãå€
éã«ååšããããšãå ±åããJ.Steroid
BiochemistryïŒ11ïŒ609ïŒ1979ïŒããããã«æè¿ã§
ã¯åç«è ºè¥å€§çæ£è ã®åç«è ºã§ã¯5αâãªãã¯ã¿
ãŒãŒã®æŽ»æ§ãç°åžžäº¢é²ããŠããããšãç¥ãããŠã
ããJ.Cinical Endocrinol.and MetaboliemïŒ
56ïŒ139ïŒ1983ïŒããåç«è ºè¥å€§çã®çºçåã³é²è¡ã«
ãžããããã¹ãã¹ããã³ãéèŠãªåœ¹å²ãæãããŠ
ããããšãæããã«ãªã€ãŠããã ãåŸæ¥ã®æè¡ã 以äžã®ãããªèæ¯ã®ããšã«ãæè¿ã5αâãªã
ã¯ã¿ãŒãŒé»å®³å€ã®ç 究éçºããããã«è¡ãªãããŠ
ããã æ¬çºæè çã¯å ã«ãæ§é åŒ ã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãããLanesic AcidïŒ
ãäž»æåãšãããæ€ç©ããã®æœåºç©ã5αâãªã
ã¯ã¿ãŒãŒé»å®³äœçšãæããããšãèŠãåºããç¹èš±
åºé¡ããïŒç¹éæ60â243020å·æ现æžåç §ã®ã
ãšïŒãã©ã³ãžãã¯ã¢ã·ããèªäœã¯ãã»ã³ãã³ç§ã®
ïŒçš®ã§ããæ€ç©ã®æç®ããåŸãããæœåºç©ã®ã²ãš
ã€ã§ããã1967幎ãã1968幎ã«ãããåé¢åã³æ§
é 決å®ããªãããå ¬ç¥ååç©ã§ããã
ãTetrahedron LettersïŒ37ïŒ3571ïŒ1967ïŒåã³å
èªïŒ34ïŒ3731ïŒ1968ïŒïŒä»¥äžãæç®ââãšç¥èšã
ããïŒåç §ã®ããšããããã®æçšæ§ã«ã€ããŠã¯ãã
ãŸã§å šãæããã«ãããŠããããæ¬çºæè çãå
ããŠèŠãåºãããã®ã§ããã ãçºæã®ç®çã æ¬çºæè ãã¯ããããã®ç¥èŠã«åºã¥ãã5αâ
ãªãã¯ã¿ãŒãŒã®äœçšã匷åã«é»å®³ããè±æ¯çãã¢
ã¯ãåã³åç«è ºè¥å€§ççã®ãããªãªãžããããã¹
ãã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çå
ã³ïŒãŸãã¯äºé²ã«æçšã§ãã5αâãªãã¯ã¿ãŒãŒ
é»å®³å€ãèŠãåºãã¹ãéæç 究ãè¡ãªããä»åã©
ã³ãžãã¯ã¢ã·ããã®ãšã¹ãã«èªå°äœåã³ã¢ããèª
å°äœãæ°èŠã«åæãããšããããããã®ååç©ã
5αâãªãã¯ã¿ãŒãŒé»å®³äœçšãæããããšãèŠã
åºããæ¬çºæãå®æããã ã©ã³ãžãã¯ã¢ã·ããã®ãšã¹ãã«é¡åã³ã¢ããé¡
ãšããŠã¯ãåè¿°ã®æç®ââã«ãã®ãžã¡ãã«ãšã¹
ãã«ãé瀺ãããŠãããããã®ä»ã®ãšã¹ãã«é¡å
ã³ã¢ããé¡ã«ã€ããŠã¯å šãèšèŒãããŠããããã
ã以åŸãæããã«ãããŠããªãããšãããå šãæ°
èŠãªååç©ã§ããã æç®ââã«ãããŠããžã¡ãã«ãšã¹ãã«ã¯ã©ã³
ãžãã¯ã¢ã·ããèªäœã®ååŠæ§é ãåå®ããããã®
æ段ãšããŠåæãããæ§é 解æãããŠããã ãã§
ãã€ãŠãè¬çäœçšã®ç¢ºèªçã®æçšæ§ã®æ€èšã¯å šã
ãªãããŠããªããåŸã€ãŠãæ¬çºæã«å«ãŸãããšã¹
ãã«é¡åã³ã¢ããé¡ã®æçšæ§ïŒ5αâãªãã¯ã¿ãŒ
ãŒé»å®³äœçšãæããŠãããåŸã€ãŠãžããããã¹ã
ã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çåã³ïŒ
ãŸãã¯äºé²ã«æçšã§ããããšïŒã«ã€ããŠã¯ãä»å
åããŠèŠãåºãããããšã§ããã ãçºæã®æ§æã åŸã€ãŠãæ¬çºæã¯äžè¬åŒ ãåŒäžã(i)R1åã³R2ã¯ãããããäžæ¹ãæ°Žé žåº
ãè¡šãããä»æ¹ãççŽ æ°ïŒã12ã®çŽéãŸãã¯åæ
éã¢ã«ã³ãã·åºãããšããã·åºãã¢ããåºããã
ã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§ç€ºãããåºïŒåŒ
äžãR3ã¯ççŽ æ°ïŒãïŒã®çŽéãŸãã¯åæéã¢ã«
ãã«åºãè¡šãããïŒãè¡šãããããããã¯(ii)R1å
ã³R2ã¯ãšãã«åãåºãè¡šãããççŽ æ°ïŒã12ã®
çŽéãŸãã¯åæéã¢ã«ã³ãã·åºãããšããã·åºã
ã¢ããåºãããã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§
瀺ãããåºïŒåŒäžãR3ã¯åèšãšåãæå³ãè¡šã
ããïŒãè¡šããããã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãã
èªå°äœãåã³R1ãŸãã¯R2ãæ°Žé žåºãè¡šããå Žå
ã«ã¯ããã®éæ¯æ§å¡©ã§ããæ°èŠãªèªå°äœã«é¢ã
ãã äžè¬åŒïŒïŒã«ãããŠãR1åã³R2ã®ãããã
äžæ¹ãæ°Žé žåºãè¡šããå ŽåïŒããªãã¡ãã©ã³ãžã
ã¯ã¢ã·ããäžã«ååšãããµãã€ã®ã«ã«ããã·ã«åº
ã®ãã¡ãããããäžæ¹ã®ã¿ããšã¹ãã«åãŸãã¯ã¢
ããåãããŠããå ŽåïŒã«ã¯ãæ¬çºæååç©ã¯ã©
ã³ãžãã¯ã¢ã·ããã¢ããšã¹ãã«ãŸãã¯ã©ã³ãžãã¯
ã¢ã·ããã¢ãã¢ãããšããŠåœåããããšãã§ã
ããR1åã³R2ã®å®çŸ©ããããããããã«ãã©ã³
ãžãã¯ã¢ã·ããã¢ããšã¹ãã«ãŸãã¯çžåœããã¢ã
ã¢ããã«ã¯ãäžè¬åŒ åã³ ãåŒäžãR1båã³R2bã¯ãççŽ æ°ïŒã12ã®çŽéãŸ
ãã¯åæéã¢ã«ã³ãã·åºãããšããã·åºãã¢ãã
åºãããã¯åŒâNHR3bãŸãã¯âïŒR3bïŒ2ã§ç€ºã
ããåºïŒåŒäžãR3bã¯ççŽ æ°ïŒãïŒã®çŽéãŸãã¯
åæéã¢ã«ãã«åºãè¡šãããïŒãè¡šããããã§ç€ºã
ãããµãã€ã®ã¢ãâ眮æäœãèããããããæ¬çº
æã«ãããŠãç¹å®ã®è¡šç€ºãè¡ãªããåã«ã¢ããšã¹
ãã«ãŸãã¯ã¢ãã¢ãããšããè¡šçŸãçšããå Žåã«
ã¯ãäžè¬åŒïŒïœâïŒïŒã§ç€ºãããååç©åã³äž
è¬åŒïŒïœâïŒïŒã§ç€ºãããååç©åã³ãããã®
æ··åç©ãå«ããã®ãšããã ãŸããäžè¬åŒïŒïŒã«ãããŠãR1åã³R2ããš
ãã«æ°Žé žåºãè¡šãããªãå ŽåïŒããªãã¡ããµãã€
ã®ã«ã«ããã·ã«åºããšãã«ãšã¹ãã«åãŸãã¯ã¢ã
ãåãããŠããå ŽåïŒã«ã¯ãæ¬çºæååç©ã¯ã©ã³
ãžãã¯ã¢ã·ãããã¹ïŒãŸãã¯ãžïŒãšã¹ãã«ãŸãã¯
ã©ã³ãžãã¯ã¢ã·ãããã¹ïŒãŸãã¯ãžïŒã¢ãããšã
ãŠåœä»€ããããšãã§ããã äžè¬åŒïŒïŒã«ãããŠãR1åã³R2ã§è¡šããã
ãççŽ æ°ïŒã12ã®ã¢ã«ã³ãã·åºãšããŠã¯ãã¡ãã
ã·ããšããã·ãããããã·ããããã·ããã³ãã«
ãªãã·ïŒã¢ãã«ãªãã·ïŒãããã·ã«ãªãã·ããã
ãã«ãªãã·ããªã¯ãã«ãªãã·ãããã«ãªãã·ãã
ã·ã«ãªãã·ããŠã³ãã·ã«ãªãã·ãããã·ã«ãªãã·
åºåã³ãããã®ç°æ§äœãæãããããããã®åºã
奜ãŸããã äžè¬åŒ(1)ã«ãããŠãR3åã³R3aã§è¡šããããç
çŽ æ°ïŒã12ã®ã¢ã«ãã«åºãšããŠã¯ãã¡ãã«ããšã
ã«ããããã«ãããã«åºåã³ãããã®ç°æ§äœãæ
ãããããããã®åºã奜ãŸããã äžè¬åŒïŒïŒã«ãããŠR1åã³R2ãè¡šããåºãš
ããŠã¯ãæ°Žé žåºãã¢ã«ã³ãã·åºãããšããã·åºã
ã¢ããåºãåã³åŒâNHR3ãâïŒR3ïŒ2ãâ
NHR3aãŸãã¯âïŒR3aïŒã§ç€ºããããããã®å Ž
åã奜ãŸããã ããã«ãæ¬çºæã«å«ãŸããååç©ãšããŠã¯ãã©
ã³ãžãã¯ã¢ã·ããã®ã¢ã眮æäœïŒã¢ããšã¹ãã«ãŸ
ãã¯ã¢ãã¢ããïŒåã³åãã¹ïŒãŸãã¯ãžïŒçœ®æäœ
ããã¹ïŒãŸãã¯ãžïŒãšã¹ãã«ãŸãã¯ãã¹ïŒãŸãã¯
ãžïŒã¢ãããã®ãããã®å Žåã奜ãŸããã äžè¬åŒ(1)ã§ç€ºãããååç©ã®éæ¯æ§å¡©ãšããŠ
ã¯ãäŸãã°ãããªãŠã ãŸãã¯ã«ãªãŠã ã®åŠãã¢ã«
ã«ãªéå±ã®å¡©ãã«ã«ã·ãŠã åã¯ãã°ãã·ãŠã ã®åŠ
ãã¢ã«ã«ãªåé¡éå±ã®å¡©ãã¢ã³ã¢ããŠã å¡©åã³è¬
åŠçã«èš±å®¹ãããïŒéæ¯æ§ã®ïŒã¢ãã³å¡©ãå«ãŸã
ããã«ã«ãã³é žãšãã®ãããªå¡©ã圢æããé©åœãª
ã¢ãã³ã¯ããç¥ãããŠãããäŸãã°ããã©ã¡ãã«
ã¢ã³ã¢ããŠã ã®åŠãããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã
ã®å¡©ãåã³ã¡ãã«ã¢ãã³å¡©ããžã¡ãã«ã¢ãã³å¡©ã
ã·ã¯ããã³ãã«ã¢ãã³å¡©ããã³ãžã«ã¢ãã³å¡©ãã
ãšããã«ã¢ãã³å¡©ããããªãžã³å¡©ãã¢ããšã¿ããŒ
ã«ã¢ãã³å¡©ããžãšã¿ããŒã«ã¢ãã³å¡©ããªãžã³å¡©ã
ã¢ã«ã®ãã³å¡©ãŸãã¯ïŒ®âã¡ãã«ã°ã«ã«ãã³å¡©çã®
ææ©ã¢ãã³å¡©ãæããããã äžè¬åŒ(1)ã§ç€ºãããæ¬çºæååç©ã¯ããã¹ãŠå ¬
ç¥ã®æ¹æ³ã«ãã補é ããããšãã§ãããããªã
ã¡ãæ§é åŒ ã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãããå ¬ç¥ã®æ¹æ³ã§ãš
ã¹ãã«åãŸãã¯ã¢ããåããããšã«ãã補é ãã
ãããšã¹ãã«ååå¿åã³ã¢ããååå¿ãšããŠã¯çš®
çš®ã®æ¹æ³ãç¥ãããŠããããæ¬çºæååç©ã®è£œé
ã«ãããŠã¯ãã®ã»ãšãã©ã®æ¹æ³ãçšããããšãã§
ãããçš®ã ã®ãšã¹ãã«ååå¿åã³ã¢ããååå¿
ã¯ãããããCalvin A.BuehlerãèããSurvey
of Organic SynthesesïŒvolumeåã³ïŒã
ïŒJohn WileyïŒSonsïŒInc瀟ãã1970幎åã³1977
幎ã«çºè¡ïŒã®Chapter14åã³18ã«è©³ããèšèŒãã
ãŠããã®ã§åç §ããããã ãšã¹ãã«ååå¿ãšããŠã¯ãäŸãã° (1) ã©ã³ãžãã¯ã¢ã·ãããšææã®ã¢ã«ã³ãŒã«ãé ž
觊åªäžã«åå¿ãããæ¹æ³ã (2) ã©ã³ãžãã¯ã¢ã·ãããšææã®ãžã¢ãŸã¢ã«ã«ã³
ãçšããæ¹æ³ã (3) ã©ã³ãžãã¯ã¢ã·ãããé©åœãªæ¹æ³ã«ããé žã
ã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ã«ã³ãŒã«ãšåå¿ãããæ¹æ³ãåã³ (4) ãžã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒä»¥äžã
DCCãšèšãããïŒãŸãã¯ïŒâã¯ããâïŒâã¡ã
ã«ããªãžããŠã ãšãŒãžãïŒä»¥äžãCMPIãšç¥èš
ãããïŒã®ååšäžãã©ã³ãžãã¯ã¢ã·ãããšææ
ã®ã¢ã«ã³ãŒã«ãåå¿ãããæ¹æ³ãçãæããã
ãã (1)æ³ã¯äžæŽ»æ§ææ©æº¶åªãäŸãã°ãã³ãŒã³äžã觊
åªéã®é žãäŸãã°ç¡«é žãå¡©é žãïœâãã«ãšã³ã¹ã«
ãã³é žãäžããåããŠçŽ ã®ååšäžãŸãã¯äžååš
äžãã©ã³ãžãã¯ã¢ã·ãããšææã®ã¢ã«ã³ãŒã«ãåžž
æž©ãŸãã¯å æž©äžã«æ°æéããæ°æ¥éåå¿ãããã
ãšã«ããè¡ãªããããåå¿äžã«çæããæ°Žã¯å ±æ²ž
èžçãã¢ã¬ããŠã©ãŒã·ãŒãã¹ãçšããŠé€å»ããã®
ã奜ãŸãããç®çãšãããšã¹ãã«ã«ãã€ãŠã¯ãæ
æã®ã¢ã«ã³ãŒã«äžã«ã©ã³ãžãã¯ã¢ã·ããã溶解ã
宀枩ã§æ°æ¥éæŸçœ®ããã ãã§ç°¡åã«ãšã¹ãã«åã
é²è¡ããå Žåãããã (2)æ³ã¯ã©ã³ãžãã¯ã¢ã·ãããšææã®ãžã¢ãŸã¢ã«
ã«ã³ãäžæŽ»æ§ææ©æº¶åªãäŸãã°ãžãšãã«ãšãŒã
ã«ãé ¢é žãšãã«ãå¡©åã¡ãã¬ã³ãã¢ã»ãã³äžã宀
æž©ããâ10âã®æž©åºŠã奜ãŸããã¯ïŒâã§åå¿ãã
ãããšã«ããè¡ãªãããã (3)æ³ã¯ã©ã³ãžãã¯ã¢ã·ãããäžæŽ»æ§ææ©æº¶åªã
äŸãã°å¡©åã¡ãã¬ã³ãããã©ããããã©ã³ãïŒ
âãžã¡ãã«ãã«ã ã¢ããäžãã·ãŠãŠé žãžã¯ãã©
ã€ããã¯ããã®é žã€ãœããã«ãŸãã¯ãããã€ã«ã¯
ãã©ã€ãçãçšããŠå®€æž©ããïŒâã§åå¿ãããé ž
ãã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ã«ã³ãŒã«ãšåå¿ãããããšã«ããè¡ãªããããå
å¿ã¯ããªãšãã«ã¢ãã³ãŸãã¯ããªãžã³ã®ããšãå¡©
åºã®ååšäžã«è¡ãªãã®ã奜ãŸããã (4)æ³ã®ãã¡ãDCCãçšããæ¹æ³ã¯ãäžæŽ»æ§æ
æ©æº¶åªãäŸãã°ã¯ãããã«ã ãå¡©åã¡ãã¬ã³äžã
ããªãžã³ã®ããšãå¡©åºã®ååšäžãã©ã³ãžãã¯ã¢ã·
ãããšææã®ã¢ã«ã³ãŒã«ã宀枩ããïŒâã§åå¿ã
ããããšã«ããè¡ãªãããããŸãCMPIãçšãã
æ¹æ³ã¯ãChemistry LettersïŒ1045ïŒ1975ïŒåã³
Bull.Chem.JapanïŒ50ïŒ1863ïŒ1977ïŒã«è©³ããèš
èŒãããŠããããäŸãã°ãäžæŽ»æ§ææ©æº¶åªãäŸã
ã°å¡©åã¡ãã¬ã³ãã¢ã»ãã³ãã¢ã»ããããªã«ãã
ããµã³ããã³ãŒã³ããã«ãšã³äžã奜ãŸããã¯ããª
ãšãã«ã¢ãã³ãããªãžã³ãïŒâãžã¡ãã«ã¢ããã
ãªãžã³ã®ããšãå¡©åºã®ååšäžãã©ã³ãžãã¯ã¢ã·ã
ããšææã®ã¢ã«ã³ãŒã«ãšCMPIã宀枩ãã50âã§
æ°æéåå¿ãããããšã«ããè¡ãªãããã ã¢ããååå¿ãšããŠã¯ãäŸãã° (1) ã©ã³ãžãã¯ã¢ã·ãããé©åœãªæ¹æ³ã«ããé žã
ã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ãã³ãšåå¿ãããæ¹æ³ãåã³ (2) ã©ã³ãžãã¯ã¢ã·ãããŸãã¯ã©ã³ãžãã¯ã¢ã·ã
ãã®ãšã¹ãã«ãšææã®ã¢ãã³ãåå¿ãããæ¹
æ³ãçãæããããã (1)æ³ã¯ãåèšãããšã¹ãã«åæ³ã®(3)æ³ãšåæ§ã®
æ¹æ³ã§ã©ã³ãžãã¯ã¢ã·ããã®é žãã©ã€ããŸãã¯æ··
åé žç¡æ°Žç©ãžå°ããåŸãææã®ã¢ãã³ãšå®€æž©ã§å
å¿ãããããšã«ããè¡ãªããããåå¿ã¯ããªãšã
ã«ã¢ãã³ãŸãã¯ããªãžã³ã®ããšãå¡©åºã®ååšäžã«
è¡ãªãã®ã奜ãŸããã (2)æ³ã¯ãã¡ã¿ããŒã«ãŸãã¯ãšã¿ããŒã«ã®ãããª
äœçŽã¢ã«ã«ããŒã«äžã奜ãŸããã¯å¡©åã¢ã³ã¢ããŠ
ã ã®ååšäžãã©ã³ãžãã¯ã¢ã·ãããŸãã¯ãã®ãšã¹
ãã«ãšææã®ã¢ãã³ãã50âãã溶åªã®éæµæž©åºŠ
ã§æ°æéåå¿ãããããšã«ããè¡ãªãããã åèšãããšã¹ãã«ååå¿åã³ã¢ããååå¿ã«ã
ããŠã¯ãã©ã³ãžãã¯ã¢ã·ããïŒã¢ã«ã«å¯ŸããŠãæ
æã®ã¢ã«ã³ãŒã«ãŸãã¯ã¢ãã³ã¯0.5ã¢ã«ãã倧é
å°ã奜ãŸããã¯ïŒããïŒã¢ã«çšããããããã®ã
ãã«åŸãããçæç©ã¯ãã¢ã眮æäœãšãã¹ïŒãžïŒ
眮æäœã®æ··åç©ã§ããã®ã§ãå ¬ç¥ã®æ¹æ³ãäŸãã°
åçµæ¶ãããã¯ã·ãªã«ã²ã«ãŸãã¯ã±ã€é žãã°ãã·
ãŠã ãçšããé«é液äœã¯ãããã°ã©ãã€ãèå±€ã¯
ãããã°ã©ãã€ããŸãã¯ã«ã©ã ã¯ãããã°ã©ãã€
çã®æ¹æ³ã«ããåé¢ç²Ÿè£œããããšãã§ããã åºçºåæãšããŠçšããã©ã³ãžãã¯ã¢ã·ããã¯ç¹
éæ60â243020å·æ现æžã«èšèŒãããæ¹æ³ã«ã
ããã©ã³ãžãŠã ãã¡ã¹ãã«ã ãžã€ãã¯ããŒãžãŠãŒ
ã¯çã®æç®ããæœåºåé¢ããããšãã§ãããä»æ¹
ã®åæãšãªãã¢ã«ã³ãŒã«é¡ãŸãã¯ã¢ãã³é¡ã¯å ¬ç¥
ååç©ãããããã¯å ¬ç¥ã®æ¹æ³ã«ãã容æã«è£œé
ãããã äžè¬åŒ(1)ã§ç€ºãããååç©ã®éæ¯æ§å¡©ã¯å ¬ç¥ã®
æ¹æ³ã«ãã補é ãããã ãå¹æã æ¬çºæã®äžè¬åŒïŒïŒã§ç€ºãããã©ã³ãžãã¯ã¢
ã·ããèªå°äœãåã³R1ãŸãã¯R2ãæ°Žé žåºãè¡šã
ãå Žåã«ã¯ããã®éæ¯æ§å¡©ã¯ã5αâãªãã¯ã¿ãŒ
ãŒé»å®³äœçšãæããã®ã§ãåºä¹³åç©ãç¹ã«ããã«
ããã5αâãªãã¯ã¿ãŒãŒã«ãããžããããã¹ã
ã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çåã³ïŒ
ãŸãã¯äºé²ã«æçšã§ããããã®ãããªçŸæ£ãšããŠ
ã¯ãäŸãã°ç·æ§åè±æ¯çãã¯ãããšããè±æ¯çã
ã¢ã¯ãåã³åç«è ºè¥å€§çãæããããã æ¬çºæååç©ã®5αâãªãã¯ã¿ãŒãŒé»å®³äœçšã¯ã
以äžã«è¿°ã¹ãã¹ã¯ãªãŒãã³ã°ç³»ã«ãã確èªãã
ãã 5αâãªãã¯ã¿ãŒãŒã«å¯Ÿããé»å®³äœçš (1) å®éšæ¹æ³ J.Shimazakiãã®æ¹æ³ãEndocrinolïŒ
Japon.ïŒ18ïŒ179ïŒ1971ïŒåç §ã®ããšããåèã«
ããŠè¡ãªã€ããããªãã¡éæ§ã©ããã®åç«è ºïŒ
ïœãïŒå容ã®0.25Mã·ãŠç³ãå«ã0.1MHEPES
ïŒPH7.4ïŒã§ãã¢ããžããŒãããåŸé å¿åé¢ãã
ïŒ3000rpmã§10åéïŒãæ²æ®¿ãäžèšç·©è¡æ¶²10mlã«
æžæ¿ããåã³é å¿åé¢ïŒ3000rpmã§ïŒåéïŒã
ãŠåŸãããæ²æž£ã«äžèšç·©è¡æ¶²ïŒmlãå ããŠæžæ¿
ããé µçŽ æº¶æ¶²ãšããã é µçŽ æŽ»æ§ã®æž¬å®ã¯ãïŒâ14Cãâãã¹ãã¹ã
ãã³ïŒ1.5nmolïŒ1.5Ã105cpmïŒãNADPH
ïŒ0.5ÎŒmolïŒãäžèšé µçŽ 溶液ïŒ0.03mlïŒåã³çš®ã
ã®æ¿åºŠïŒ2mMã1mMåã³0.2mMïŒã®æ€äœãå«
ãå šå®¹0.1mlã®åå¿æº¶æ¶²ã37âã§60åéã€ã³ã
ãŠããŒããããé µçŽ åå¿ã¯ã¯ãããã«ã ãšã¡ã¿
ããŒã«ïŒïŒïŒïŒïŒã®æ··å液0.4mlãå ããŠåæ¢
ãããã®åŸé å¿åé¢ïŒ2000rpmã§ïŒåéïŒãã
åŸãããäžæž 50ÎŒãã·ãªã«ã²ã«èå±€ãã¬ãŒã
ã«ã¹ãããããã¯ãããã«ã ãã¡ã¿ããŒã«åã³
é ¢é žïŒ99.2ïŒ0.6ïŒ0.2ïŒã®æ··å液ãçšããŠåé¢
ããããã¬ãŒãããªãŒãã©ãžãªã°ã©ãã€ã«ã
ããçæãããžããããã¹ãã¹ããã³ã®æŸå°æŽ»
æ§ãTLCã¹ãã€ããŒãçšããŠæž¬å®ããé µçŽ æŽ»
æ§é»å®³çãç®åºãããçµæãè¡šïŒã«ç€ºãã (2) çµæ ãè¡šã å®éšçµæãããæ¬çºæååç©ã¯ã5αâãªãã¯
ã¿ãŒãŒé»å®³äœçšãæããããšã確èªããããåŸã€
ãŠãåºä¹³åç©ãç¹ã«ããã«ããã5αâãªãã¯ã¿
ãŒãŒã«ãããžããããã¹ãã¹ããã³ã®ç£çéå°ã«
èµ·å ããçŸæ£ã®æ²»çåã³ïŒãŸãã¯äºé²ã«æçšã§ã
ããããã«ãæ¬çºæååç©ã®æ¯æ§ã¯éåžžã«äœãã
ã®ã§ãããå»è¬åãšããŠååå®å šã«äœ¿çšã§ããã
ãšã確èªãããã æ¬çºæã«å«ãŸããååç©ãäžèšã®ç®çã§çšãã
ã«ã¯ãéåžžå šèº«çïŒäž»ãšããŠåç«è ºè¥å€§çã®æ²»ç
åã³ïŒãŸãã¯äºé²ã®å ŽåïŒãŸãã¯å±æçïŒäž»ãšã
ãŠè±æ¯çåã³ã¢ã¯ãã®æ²»çåã³ïŒãŸãã¯äºé²ã®å Ž
åïŒã«ãçµå£ãŸãã¯éçµå£ã§æäžããããæäžé
ã¯å¹Žä»€ãäœéãçç¶ãæ²»çå¹æãæäžæ¹æ³ãåŠç
æéçã«ããç°ãªãããåç«è ºè¥å€§çã®æ²»çå
ã³ïŒãŸãã¯äºé²ã®å Žåã¯ãéåžžæ人ã²ãšãåœãã
ïŒåã«ïŒmgãïŒïœã奜ãŸããã¯20mgã200mgã®ç¯
å²ã§ïŒæ¥ïŒåããæ°åçµå£æäžããããããŸãã¯
æ人ã²ãšãåœããïŒåã«100ÎŒïœã100mgã奜ãŸã
ãã¯ïŒmgã10mgã®ç¯å²ã§ïŒæ¥ïŒåããæ°åéçµå£
æäžïŒå¥œãŸããã¯éèå æäžïŒããããè±æ¯çå
ã³ã¢ã¯ãã®æ²»çåã³ïŒãŸãã¯äºé²ã®å Žåã¯ãéåžž
æ人ã²ãšãåœããïŒåã«10ÎŒïœã50mgã奜ãŸãã
ã¯100ÎŒïœãïŒmgã®ç¯å²ã§ïŒæ¥ïŒåããæ°åçµç®
æäžãããããã¡ããåèšããããã«æäžéã¯
çš®ã ã®æ¡ä»¶ã§å€åããã®ã§ãäžèšæäžç¯å²ããå°
ãªãéã§ååãªå ŽåããããããŸãç¯å²ãè¶ããŠ
æäžããå¿ èŠã®ããå Žåãããã æ¬çºæã«ããçµå£æäžã®ããã®åºäœçµæç©ãšã
ãŠã¯ãé å€ãæ£å€ãé¡ç²å€çãå«ãŸããããã®ã
ããªåºäœçµæç©ã«ãããŠã¯ãã²ãšã€ãŸãã¯ãã以
äžã®æŽ»æ§ç©è³ªããå°ãªããšãã²ãšã€ã®äžæŽ»æ§ãªåž
éå€ãäŸãã°ä¹³ç³ããã³ãããŒã«ããããŠç³ãã
ãããã·ãããã«ã»ã«ããŒã¹ã埮çµæ¶ã»ã«ããŒ
ã¹ããã³ãã³ãããªããã«ãããªãã³ãã¡ã¿ã±ã€
é žã¢ã«ãã³é žãã°ãã·ãŠã ãšæ··åããããçµæç©
ã¯ãåžžæ³ã«åŸã€ãŠãäžæŽ»æ§ãªåžéå€ä»¥å€ã®æ·»å
å€ãäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã®ãããªæœ€
æ»å€ãç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ã®ãããªåŽ©å£
å€ãå«æããŠããŠããããé å€ãŸãã¯äžžå€ã¯å¿ èŠ
ã«ããçœç³ããŒã©ãã³ãããããã·ãããã«ã»ã«
ããŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ã
ã¿ã¬ãŒããªã©ã®è溶æ§ãããã¯è žæº¶æ§ç©è³ªã®ãã€
ã«ã ã§è¢«èããŠããããããŸãïŒä»¥äžã®å±€ã§è¢«è
ããŠããããããã«ãŒã©ãã³ã®ãããªåžåããã
ãç©è³ªã®ã«ãã»ã«ãå å«ãããã çµå£æäžã®ããã®æ¶²äœçµæç©ã¯ãè¬å€çã«èš±å®¹
ãããä¹³æ¿å€ã溶液å€ãæžæ¿å€ãã·ãããå€ããš
ãªãã·ã«å€çãå«ã¿ãäžè¬çã«çšããããäžæŽ»æ§
ãªåžéå€ãäŸãã°ç²Ÿè£œæ°Žããšã¿ããŒã«ãå«ããã
ã®çµæç©ã¯äžæŽ»æ§ãªåžéå€ä»¥å€ã«æ¹¿æœ€å€ãæžæ¿å€
ã®ãããªè£å©å€ãçå³å€ã颚å³å€ãè³éŠå€ãé²è
å€ãå«æããŠããŠãããã çµå£æäžã®ããã®ãã®ä»ã®çµæç©ãšããŠã¯ãã²
ãšã€ãŸããã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœå ¬
ç¥ã®æ¹æ³ã«ããåŠæ¹ãããã¹ãã¬ãŒå€ãå«ãŸããŠ
ããã æ¬çºæã«ããéçµå£æäžã®ããã®æ³šå°å€ãšããŠ
ã¯ãç¡èã®æ°Žæ§ãŸãã¯éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ã
ä¹³æ¿å€ãå å«ãããæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠ
ã¯äŸãã°æ³šå°çšèžçåã³ççé£å¡©æ°Žãå«ãŸããã
éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠã¯ãäŸãã°ããã
ã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ããªãª
ãŒãæ²¹ã®ãããªæ€ç©æ²¹ããšã¿ããŒã«ã®ãããªã¢ã«
ã³ãŒã«é¡ãããªãœã«ããŒã80çãããããã®ãã
ãªçµæç©ã¯ãããã«é²è å€ã湿最å€ãä¹³åå€ãå
æ£å€ã®ãããªè£å©å€ãå«ãã§ãããããããã¯äŸ
ãã°ãã¯ããªã¢ä¿çãã€ã«ã¿ãŒãéãéã殺è
å€ã®é åãŸãã¯ç §å°ã«ãã€ãŠç¡èåãããããã
ãã¯ãŸãç¡èã®åºäœçµæç©ã補é ãã䜿çšåã«ç¡
èæ°ŽãŸãã¯ç¡èã®æ³šå°çšæº¶åªã«æº¶è§£ããŠäœ¿çšãã
ããšãã§ããã éçµå£æäžã®ããã®ãã®ä»ã®æç©ãšããŠã¯ãã²
ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœ
å ¬ç¥ã®æ¹æ³ã«ããåŠæ¹ããããå€çšæ¶²å€ãè»ã³ãŠ
ã®ãããªå¡åžå€ãçŽè¹å æäžã®ããã®åå€åã³è£
å æäžã®ããã®ãããµãªãŒçãå«ãŸããã ç¹ã«è±æ¯çãŸãã¯ã¢ã¯ãã®æ²»çåã³äºé²ã®ãã
ã®çµç®æäžçšã®çµæç©ãšããŠã¯ãããŒã·ãšã³ãã
ããã¯ãã¹ãã¬ãŒã溶液å€ãæžæ¿å€ã乳液ã®ãã
ãªå€çšæ¶²å€åã³è»ã³ãŠãã²ã«ãã¯ãªãŒã ã®ãããª
å¡åžå€ãå«ãŸããããã®ãããªçµæç©ã«ãããŠ
ã¯ãã²ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªããå°ãªã
ãšãã²ãšã€ã®äžæŽ»æ§ãªåžéå€ãäŸãã°èžçæ°Žããš
ã¿ããŒã«ã®ãããªäœçŽã¢ã«ã³ãŒã«ãã»ã¿ããŒã«ã®
ãããªé«çŽã¢ã«ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ããããã¬ã³ã°ãªã³ãŒã«ã®ãããªå€äŸ¡ã¢ã«ã³ãŒ
ã«ãããããã·ãããã«ã»ã«ããŒã¹ã®ãããªã»ã«
ããŒã¹é¡ãåç©æ§åã³æ€ç©æ§ã®èèªãã¯ã»ãªã³ã
ããŠãã·ãªã³ã³ããªãªãŒãæ²¹ã®ãããªæ€ç©æ²¹ãç
é¢æŽ»æ§å€ãé žåäºéçãå«ãããã®çµæç©ã¯äžèš
ã®åžéå€ä»¥å€ã«ãã湿最å€ãæžæ¿å€ãè³éŠå€ãé²
è å€ã®ãããªè£å©å€ãå«ãã§ãããã æ¬çºæã«å«ãŸããäžè¬åŒ(1)ã§ç€ºãããååç©ã®
ãã¡ã奜ãŸãããã®ãšããŠã¯ãäŸãã°ãã©ã³ãžã
ã¯ã¢ã·ããã®ã¢ãã¡ãã«ãšã¹ãã«ãã¢ããšãã«ãš
ã¹ãã«ãã¢ããããã«ãšã¹ãã«ãã¢ãããã«ãšã¹
ãã«ãã¢ãã¢ãããšã¹ãã«ãã¢ãããã·ã«ãšã¹ã
ã«ãã¢ããããã«ãšã¹ãã«ãã¢ããªã¯ãã«ãšã¹ã
ã«ãã¢ãããã«ãšã¹ãã«ãã¢ããã·ã«ãšã¹ãã«ã
ã¢ããŠã³ãã·ã«ãšã¹ãã«ãã¢ãããã·ã«ãšã¹ã
ã«ãã¢ãããšãã«ãšã¹ãã«ãã¢ãã¢ãããã¢ãâ
âã¡ãã«ã¢ãããã¢ãââãšãã«ã¢ãããã¢
ãââãããã«ã¢ãããã¢ãââããã«ã¢ã
ããã¢ãâïŒïŒ®âãžã¡ãã«ã¢ãããã¢ãâïŒ
âãžãšãã«ã¢ãããã¢ãâïŒïŒ®âãžãããã«
ã¢ãããã¢ãâïŒïŒ®âãžããã«ã¢ãããåã³ã
ããã«çžåœãããžïŒåã¯ãã¹ïŒãšã¹ãã«ïŒãã
ãããžã¡ãã«ãšã¹ãã«ã¯é€ããïŒåã³åã¢ããã
åã³ãããã«çžåœããã¢ã«ãã«éšåã®ç°æ§äœãå
ã³ãããã®éæ¯æ§å¡©ãæããããšãã§ããã ãå®æœäŸã 以äžãåèäŸåã³å®æœäŸã«ããæ¬çºæã詳述ã
ãããæ¬çºæã¯ãããã®å®æœäŸã«éå®ããããã®
ã§ã¯ãªãããªãåèäŸåã³å®æœäŸäžã®ãTLCãã
ãNMRãããIRãåã³ãMSãã¯ãåã ãèå±€ã¯ã
ããã°ã©ãã€ãããæ žç£æ°å ±é³Žã¹ãã¯ãã«ãããèµ€å€
åžåã¹ãã¯ãã«ãåã³ã質éåæããè¡šãããã¯
ãããã°ã©ãã€ã«ããåé¢ã®ç®æã«èšèŒãããŠã
ãã«ãã³å ã®æº¶åªã¯äœ¿çšãã溶åºæº¶åªãŸãã¯å±é
溶åªãäœç©æ¯ã§ç€ºããŠãããç¹å¥ã®èšèŒããªãå Ž
åã«ã¯ãIRã¯ã¯ãããã«ã 溶液ã§æž¬å®ããNMR
ã¯éã¯ãããã«ã ïŒCDCl3ïŒæº¶æ¶²ã§æž¬å®ããŠã
ãã çæç©ã®ãã¡ãã¢ããšã¹ãã«ãŸãã¯ã¢ãã¹ã¢ã
ãã¯äžè¬åŒïŒ1bâïŒïŒã§ç€ºãããååç©ãšäžè¬
åŒïŒ1bâïŒïŒã§ç€ºãããååç©ã®æ··åç©ã§ããã å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«åã³å
ãžãšãã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ããïŒïœããšã¿ããŒã«ïŒmlãã
ã³ãŒã³20mlãã¢ãããŠã©ãŒã·ãŒãã¹4A ïŒïœåã³
觊åªéã®ïœâãã«ãšã³ã¹ã«ãã³é žã®æ··åç©ã宀枩
ã§ïŒæ¥éæŸçœ®ããŠåå¿ããããåå¿æ··åç©ãé
ãã液ãæžå§æ¿çž®ãããåŸãããæ®çç©ãã·ãª
ã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšãã«ïŒïœ
âãããµã³ïŒïŒïŒïŒâïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®
ç©æ§æ€ãæããæšé¡ååç©ãã¢ããšãã«ãšã¹ãã«
ïŒç¡è²æ²¹ç¶ïŒ380mgãšãžãšãã«ãšã¹ãã«ïŒçœè²çµ
æ¶ïŒ120mgãåŸãã (a) ã¢ããšãã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.60ïŒ NMRïŒÎŽ5.38ïŒ1HïŒïœïŒã4.96â4.54ïŒ6HïŒ
ïœïŒã4.13åã³4.11ïŒåãããŠ2HïŒåã ïœïŒã
1.80ïŒ3HïŒbsïŒã1.73ïŒ6HïŒbsïŒã1.25ïŒ3HïŒ
ïœïŒã0.93åã³0.91ïŒåãããŠ3HïŒåã ïœïŒã
0.73ïŒ3HïŒïœïŒïŒ IRïŒÎœ2920ã1715ã1625ã1435ã1170ã1110ã
890cm-1ïŒ MSïŒïœïŒe498ã453ã397. (b) ãžãšãã«ãšã¹ãã« èç¹ïŒ44â46.5âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒïŒ
Rf0.35ïŒ NMRïŒÎŽ5.36ïŒ1HïŒïœïŒã4.93â4.55ïŒ6HïŒ
ïœïŒã4.09åã³4.08ïŒåã 2HïŒïœïŒã1.77ïŒ6HïŒ
bsïŒã1.73ïŒbsïŒã1.24ïŒ6HïŒïœïŒã0.92ïŒ3HïŒ
ïœïŒã0.71ïŒ3HïŒïœïŒïŒ IRïŒÎœ2930ã1720ã1630ã1435ã1175ã1110ã
1020ã890cm-1ïŒ MSïŒïœïŒe256ã481ã425. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãã ã¢ãã€ãœãããã«ãšã¹ã
ã«åã³åãžã€ãœãããã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ãã470mgãã€ãœãããããŒã«
120mgãïŒâã¯ããâïŒâã¡ãã«ããªãžããŠã ãš
ãŒãžã383mgãããªãšãšãã«ã¢ãã³ïŒmlã觊åªé
ã®ïŒâãžã¡ãã«ã¢ããããªãžã³åã³å¡©åã¡ãã¬ã³
10mlã®æ··åç©ã宀枩ã§ïŒæéãããŸãããåå¿æ··
åç©ãå¡©åã¡ãã¬ã³30mlã§åžéããåŸãæ°ŽæŽãã
ç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ãããçç©
ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšã
ã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®ç©
æ§å€ãæããæšé¡ååç©ãã¢ãã€ãœãããã«ãšã¹
ãã«ïŒç¡è²æ²¹ç¶ïŒ87mgãšãžã€ãœãããã«ãšã¹ãã«
ïŒç¡è²æ²¹ç¶ïŒ221mgãåŸãã (a) ã¢ãã€ãœãããã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.59ïŒ NMRïŒÎŽ5.37ïŒ1HïŒïœïŒã5.12â4.54ïŒ7HïŒ
ïœïŒã1.75ïŒ3HïŒbsïŒã1.73ïŒ6HïŒbsïŒã1.23
ïŒ6HïŒïœïŒã0.82åã³0.81ïŒåãããŠ3HïŒåã
ïœïŒã0.73åã³0.72ïŒåãããŠ3HïŒåã ïœïŒïŒ IRïŒÎœ2930ã1710ã1630ã1440ã1370ã1280ã
1240ã1170ã1140ã1100ã1040ã890cm-1ïŒ MSïŒïœïŒe512ã453ã439ã397. (b) ãžã€ãœãããã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒïŒ
Rf0.375ïŒ NMRïŒÎŽ5.36ïŒ1HïŒïœïŒã5.04â4.54ïŒ8HïŒ
ïœïŒã1.78ïŒ3HïŒbsïŒã1.74ïŒ6HïŒbsïŒã1.22
ïŒ6HïŒïœïŒã0.84ïŒ3HïŒïœïŒã0.71ïŒ3HïŒïœïŒïŒ IRïŒÎœ2930ã1720ã1440ã1380ã1280ã1170ã
1110ã900cm-1ïŒ MSïŒïœïŒe554ã495ã439. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãããžããšãã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ãã470mgãšã·ãŠãŠé žã¯ããªã
ïŒmlã®æ··åç©ã宀枩ã§30åéãããŸããåŸæžå§æ¿
çž®ããŠãã©ã³ãžãã¯ã¢ã·ããã®é žãã©ã€ããåŸ
ããåŸãããé žãã©ã€ãã«æ°·å·äžãå¡©åã¡ãã¬ã³
ïŒmlã«æº¶ãããããšããŒã«150mgãšããªãžã³0.3ml
ãå ããŠå®€æž©ã§ïŒæéãããŸãããåå¿æ··åç©ã
é ¢é žãšãã«20mlã§åžéããåžå¡©é žåã³æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€
ïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒã§ç²Ÿè£œã
ãŠã次ã®ç©æ§å€ãæããæšé¡ååç©ïŒç¡è²æ²¹ç¶ïŒ
305mgãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.45ïŒ NMRïŒÎŽ7.36â6.92ïŒ10HïŒïœïŒã5.39ïŒ1HïŒ
ïœïŒã4.96â4.60ïŒ6HïŒïœïŒã1.81ïŒ6HïŒbsïŒã
1.76ïŒ3HïŒbsïŒã0.89åã³0.77ïŒåã 3HïŒ
ïœïŒïŒ IRïŒÎœ2950ã1750ã1640ã1600ã1500ã1385ã
1195ã1165ã900cm-1ïŒ MSïŒïœïŒe622ã529ã473ã435. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãã ã¢ãâïŒïŒ®âãžã¡ãã«
ã¢ããåã³åãã¹âïŒNâ²âãžã¡ãã«ã¢ãã ãã³ãŒã³12mlã«æº¶ãããã©ã³ãžãã¯ã¢ã·ãã
470mgã«ããªãšãã«ã¢ãã³0.7mlã宀枩ã§æ»Žäžã
ãã滎äžçµäºåŸãæ··å液ã«æ°·å·äžã€ãœããã«ã¯ã
ããã«ããŒã0.19mlãå ãã20åéãããŸããŠæ··
åé žç¡æ°Žç©ãåŸããåŸããã溶液ã«40ïŒ ãžã¡ãã«
ã¢ãã³æ°Žæº¶æ¶²ïŒmlãæ°·å·äžã«å ããïŒæéãããŸ
ãããåå¿æ··åç©ã«æ°Žãå ããé ¢é žãšãã«ã§æœåº
ããæœåºæ¶²ãæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«
ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšãã«ïŒïœâãã
ãµã³ïŒïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®ç©æ§å€ãæãã
æšé¡ååç©ãã¢ããžã¡ãã«ã¢ããïŒçœè²ç²æ«ïŒ93
mgãšãã¹ãžã¡ãã«ã¢ããïŒçœè²ç²æ«ïŒ72mgãåŸ
ãã (a) ã¢ãâïŒïŒ®âãžã¡ãã«ã¢ãã èç¹ïŒ125â135âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.47ïŒ NMRïŒÎŽ5.38ïŒ1HïŒïœïŒã4.98â4.52ïŒ6HïŒ
ïœïŒã3.05åã³3.03ïŒåã 3HïŒïœïŒã1.76ïŒ3HïŒ
bsïŒã1.74ïŒ6HïŒbsïŒã0.82åã³0.73ïŒåã 3HïŒ
ïœïŒïŒ IRïŒÎœ2950ã1720ã1600ã1450ã1410ã1390ã
1350ã900cm-1ïŒ MSïŒïœïŒe497ã424ã388. (b) ãã¹âïŒïŒ®âãžã¡ãã«ã¢ãã èç¹ïŒ132â135âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.27ïŒ NMRïŒÎŽ5.37ïŒ1HïŒïœïŒã4.92â4.54ïŒ6HïŒ
ïœïŒã4.01ã3.96ã3.90åã³3.88ïŒå3HïŒïœïŒã
1.76ïŒ6HïŒbsïŒã1.70ïŒ3HïŒbsïŒã0.84åã³0.73
ïŒåã 3HïŒïœïŒïŒ IRïŒÎœ2950ã1640ã1405ã900cm-1ïŒ MSïŒïœïŒe524ã509ã480ã438ã424ã382. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ãã¢ãã ãšã¿ããŒã«ïŒmlã«æº¶ãããã©ã³ãžãã¯ã¢ã·ãã
ã¢ããšãã«ãšã¹ãã«ïŒå®æœäŸïŒ(a)ã§è£œé ãããïŒ
100mgããªãŒãã¯ã¬ãŒãäžãã¢ã³ã¢ãã¢ã¬ã¹ãå¹
ã蟌ã¿ã100âã§ïŒæéãããŸãããåå¿æ··åç©
ãæžå§æ¿çž®ããåŸãããæ®çç©ãã·ãªã«ã²ã«ã«ã©
ã ã¯ãããã°ã©ãã€ïŒïœâãããµã³ïŒé ¢é žãšã
ã«ïŒé ¢é žïŒïŒïŒïŒïŒtraceéïŒã§ç²Ÿè£œãã次ã®ç©
æ§å€ãæããæšé¡ååç©29mgïŒçœè²ç²æ«ïŒãåŸ
ãã èç¹ïŒ139â141.5âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.41ïŒ NMRïŒÎŽ7.32ã7.00ã6.05åã³5.63ïŒNHïŒåã
ããŠ2HïŒã5.37ïŒ1HïŒïœïŒã4.94â4.54ïŒ6HïŒ
ïœïŒã1.74ïŒ6HïŒbsïŒã1.73ïŒ3HïŒbsïŒã0.79ã
0.78ã0.72åã³0.71ïŒåãããŠ6HïŒåã ïœïŒïŒ IRïŒÎœ2940ã1700ã1640ã900cm-1ïŒ MSïŒïœïŒe469ã397. 以äžãã©ã³ãžãã¯ã¢ã·ãããšãããããïœâã¢
ãã«ã¢ã«ã³ãŒã«ãïœâãã·ã«ã¢ã«ã³ãŒã«ã40ïŒ ã¡
ãã«ã¢ãã³æ°Žæº¶æ¶²åã³ã¢ã³ã¢ãã¢æ°ŽãçšããŠãã
ãããå®æœäŸïŒãïŒãïŒåã³ïŒãšåæ§ã«ããŠãäž
è¡šã«ç€ºãæ¬çºæååç©ãåŸãã ãè¡šã ãè¡šã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
é å€ã®è£œé ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ïŒïœã
ç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ïŒåŽ©å£å€ïŒ200mgã
ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒæœ€æ»å€ïŒ100mgåã³
埮çµæ¶ã»ã«ããŒã¹4.7ïœãåžžæ³ã«ããæ··åãæé
ããŠãäžé äžã«50mgã®æŽ»æ§æåãå«æããé å€
100é ãåŸãã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
ããŒã·ãšã³ã®è£œé ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«0.1ïœã
ããããã·ãããã«ã»ã«ããŒã¹ïŒHPCâïŒïŒç»
é²åæšãæ¥æ¬æ¹é補ïŒ1.1ïœåã³éŠææ°æ»Žãåžžæ³
ã«ãã80ïŒ ãšã¿ããŒã«ã«æº¶ãããå šéã100mlãš
ããŠç®çãšããããŒã·ãšã³ãåŸãã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
ã¯ãªãŒã å€ã®è£œé ããªãšãã¬ã³ã°ãªã³ãŒã«â400åã³ããªãšãã¬
ã³ã°ãªã³ãŒã«â4000ïŒããããç»é²åæšãæ¥æ¬æ²¹
è補ïŒãããã4.0ïœåã³ã»ã¿ããŒã«0.5ïœã®æ··å
ç©ã80âã«å 枩溶解ããåŸãã©ã³ãžãã¯ã¢ã·ãã
ã¢ããšãã«ãšã¹ãã«0.1ïœãå ããŠåå溶解ãã
ãŠå®€æž©ãŸã§å·åŽãããæ··åç©ã«éŠææ°æ»Žãããã«
粟補氎ãå ããªããååã«ãããŸããŠå šéã10ïœ
ãšããŠç®çãšããã¯ãªãŒã å€ãåŸãã
ã«åã³ã¢ããã«é¢ããã ãçºæã®èæ¯ã åŸæ¥ãããç·æ§åè±æ¯çã®æå ãšããŠã¯ã(1)ã
ã«ã¢ã³ã®ã¢ã³ãã©ã³ã¹èª¬ã(2)éºäŒèª¬ã(3)è¡æ¶²åŸªç°
äžå šèª¬ã(4)æ é€èª¬çæ°å€ãã®èª¬ãæå±ãããŠãã
ããæ¯ã®çºçã«ç·æ§ãã«ã¢ã³ã®ãã¹ãã¹ããã³
ïŒtestosteroneïŒãéèŠãªåœ¹å²ãæŒããŠããããš
ã¯å€ããã瀺åãããŠããããã¹ãã¹ããã³ãšç·
æ§åè±æ¯çã®å æé¢ä¿ãå®éšçã«çååŠã®ã¬ãã«
ã§èšŒæããå®éãã®èª¬ïŒBiochem.Biophys.Res.
Commun.ïŒ41ïŒ884ïŒ1970ïŒåç §ã®ããšãã«ãã
ãšãçŸäžžã§çåæããããã¹ãã¹ããã³ã¯é éšã«
ãããŠãæ¯å ãè¥èç·çã«ååšãã5αâãªãã¯
ã¿ãŒãŒïŒ5αâreductaseïŒã«ãããžããããã¹ã
ã¹ããã³ïŒDihydoroteststeroneïŒã«å€æããã
ãã®ãžããããã¹ãã¹ããã³ãã¢ããã«ãµã€ã¯ã©
ãŒãŒïŒadenyl cyclaseïŒã®æŽ»æ§ãèããäœäžãã
ãããšã«ãã现èå ã®ãµã€ã¯ãªãã¯âAMPã¬ã
ã«ã®äœäžãããããããã®çµææ¯åã³æ¯ã®åšèŸºã®
ãšãã«ã®ãŒç£çã®äœäžãšã¿ã³ãã¯è³ªåæã®æå¶ã
èªèµ·ãããåã€ãŠããããäžé£ã®çŸè±¡ã«ãããæ
é·æã«ããæ¯ã¯äŒæ¢æã«ç§»è¡ãããã®ç¶æ ããã
è¿ããŠããéã«çµæ¯ããè»æ¯ãžããããŠæçµçã«
ã¯ç·æ§åãã²ã«ãŸã§é²è¡ãããšèããããããã®
説ãè£ä»ãããã®ãšããŠãã·ãŠãã€ã±ã«ããH.
V.Schweikertããã¯ãç·æ§åãã²ã®æ¯å ã«ã¯ã
女æ§ã®æ¯å ããã²ã§ãªã人ã®æ¯å ã«æ¯ããŠã5α
âãªãã¯ã¿ãŒãŒã«ãã代è¬ç©ãããªãã¡ãžããã
ãã¹ãã¹ããã³çãå€éã«ååšããŠããããšãå ±
åããŠãããJ.Clin.Endocr.ïŒ38ïŒ811ïŒ1974ïŒå
ç §ã®ããšãã ç·æ§åè±æ¯ç以å€ã«ãããã¹ãã¹ããã³ãã
5αâãªãã¯ã¿ãŒãŒã«ããçæãããžããããã¹
ãã¹ããã³ã¯ãã¢ã¯ãïŒãç¡ããããçïŒã®çº
çãå¢æªã«ãéèŠãªççç圹å²ãæŒããŠããããš
ãå ±åãããŠãããããªãã¡ãJ.B.Hayãã¯ã¢ã¯
ãæ£éšã«ãããæ£éšã®ç®èãšæ£åžžç®èã§ã®ãã¹ã
ã¹ããã³ã®ä»£è¬é床ãæ¯èŒãããšããããã¹ãã¹
ããã³ã®5αâãªãã¯ã¿ãŒãŒã«ãã代è¬ã¯ã¢ã¯ã
æ£éšã«ãããŠäº¢é²ããŠããããšãå ±åããŠãã
ãBr.J.Dermatol.ïŒ91ïŒ123ïŒ1974ïŒãããŸãG.
Sansoneãã¯ã¢ã¯ãæ£è ã®æ£éšç®èäžã®ãã¹ãã¹
ããã³ãããžããããã¹ãã¹ããã³ãžã®åæèœ
ã¯ãæ£åžžäººã®ããã®ïŒã20åç°åžžäº¢é²ããŠããã
ãšãèŠãåºããã¢ã¯ãã®çºçãå¢æªã«å¯ŸããŠ5α
âãªãã¯ã¿ãŒãŒã«ããçæãããžããããã¹ãã¹
ããã³ã倧ããé¢äžããŠããããšã瀺åããŠãã
ãJ.Invest.Dermatol.ïŒ56ïŒ366ïŒ1971ïŒãã ããã«ããžããããã¹ãã¹ããã³ã¯åç«è ºã®è¥
倧ã«ãé¢äžããŠãããCowanãã¯åç«è ºè¥å€§ç
æ£è ã®åç«è ºäžã«ã¯ãžããããã¹ãã¹ããã³ãå€
éã«ååšããããšãå ±åããJ.Steroid
BiochemistryïŒ11ïŒ609ïŒ1979ïŒããããã«æè¿ã§
ã¯åç«è ºè¥å€§çæ£è ã®åç«è ºã§ã¯5αâãªãã¯ã¿
ãŒãŒã®æŽ»æ§ãç°åžžäº¢é²ããŠããããšãç¥ãããŠã
ããJ.Cinical Endocrinol.and MetaboliemïŒ
56ïŒ139ïŒ1983ïŒããåç«è ºè¥å€§çã®çºçåã³é²è¡ã«
ãžããããã¹ãã¹ããã³ãéèŠãªåœ¹å²ãæãããŠ
ããããšãæããã«ãªã€ãŠããã ãåŸæ¥ã®æè¡ã 以äžã®ãããªèæ¯ã®ããšã«ãæè¿ã5αâãªã
ã¯ã¿ãŒãŒé»å®³å€ã®ç 究éçºããããã«è¡ãªãããŠ
ããã æ¬çºæè çã¯å ã«ãæ§é åŒ ã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãããLanesic AcidïŒ
ãäž»æåãšãããæ€ç©ããã®æœåºç©ã5αâãªã
ã¯ã¿ãŒãŒé»å®³äœçšãæããããšãèŠãåºããç¹èš±
åºé¡ããïŒç¹éæ60â243020å·æ现æžåç §ã®ã
ãšïŒãã©ã³ãžãã¯ã¢ã·ããèªäœã¯ãã»ã³ãã³ç§ã®
ïŒçš®ã§ããæ€ç©ã®æç®ããåŸãããæœåºç©ã®ã²ãš
ã€ã§ããã1967幎ãã1968幎ã«ãããåé¢åã³æ§
é 決å®ããªãããå ¬ç¥ååç©ã§ããã
ãTetrahedron LettersïŒ37ïŒ3571ïŒ1967ïŒåã³å
èªïŒ34ïŒ3731ïŒ1968ïŒïŒä»¥äžãæç®ââãšç¥èšã
ããïŒåç §ã®ããšããããã®æçšæ§ã«ã€ããŠã¯ãã
ãŸã§å šãæããã«ãããŠããããæ¬çºæè çãå
ããŠèŠãåºãããã®ã§ããã ãçºæã®ç®çã æ¬çºæè ãã¯ããããã®ç¥èŠã«åºã¥ãã5αâ
ãªãã¯ã¿ãŒãŒã®äœçšã匷åã«é»å®³ããè±æ¯çãã¢
ã¯ãåã³åç«è ºè¥å€§ççã®ãããªãªãžããããã¹
ãã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çå
ã³ïŒãŸãã¯äºé²ã«æçšã§ãã5αâãªãã¯ã¿ãŒãŒ
é»å®³å€ãèŠãåºãã¹ãéæç 究ãè¡ãªããä»åã©
ã³ãžãã¯ã¢ã·ããã®ãšã¹ãã«èªå°äœåã³ã¢ããèª
å°äœãæ°èŠã«åæãããšããããããã®ååç©ã
5αâãªãã¯ã¿ãŒãŒé»å®³äœçšãæããããšãèŠã
åºããæ¬çºæãå®æããã ã©ã³ãžãã¯ã¢ã·ããã®ãšã¹ãã«é¡åã³ã¢ããé¡
ãšããŠã¯ãåè¿°ã®æç®ââã«ãã®ãžã¡ãã«ãšã¹
ãã«ãé瀺ãããŠãããããã®ä»ã®ãšã¹ãã«é¡å
ã³ã¢ããé¡ã«ã€ããŠã¯å šãèšèŒãããŠããããã
ã以åŸãæããã«ãããŠããªãããšãããå šãæ°
èŠãªååç©ã§ããã æç®ââã«ãããŠããžã¡ãã«ãšã¹ãã«ã¯ã©ã³
ãžãã¯ã¢ã·ããèªäœã®ååŠæ§é ãåå®ããããã®
æ段ãšããŠåæãããæ§é 解æãããŠããã ãã§
ãã€ãŠãè¬çäœçšã®ç¢ºèªçã®æçšæ§ã®æ€èšã¯å šã
ãªãããŠããªããåŸã€ãŠãæ¬çºæã«å«ãŸãããšã¹
ãã«é¡åã³ã¢ããé¡ã®æçšæ§ïŒ5αâãªãã¯ã¿ãŒ
ãŒé»å®³äœçšãæããŠãããåŸã€ãŠãžããããã¹ã
ã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çåã³ïŒ
ãŸãã¯äºé²ã«æçšã§ããããšïŒã«ã€ããŠã¯ãä»å
åããŠèŠãåºãããããšã§ããã ãçºæã®æ§æã åŸã€ãŠãæ¬çºæã¯äžè¬åŒ ãåŒäžã(i)R1åã³R2ã¯ãããããäžæ¹ãæ°Žé žåº
ãè¡šãããä»æ¹ãççŽ æ°ïŒã12ã®çŽéãŸãã¯åæ
éã¢ã«ã³ãã·åºãããšããã·åºãã¢ããåºããã
ã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§ç€ºãããåºïŒåŒ
äžãR3ã¯ççŽ æ°ïŒãïŒã®çŽéãŸãã¯åæéã¢ã«
ãã«åºãè¡šãããïŒãè¡šãããããããã¯(ii)R1å
ã³R2ã¯ãšãã«åãåºãè¡šãããççŽ æ°ïŒã12ã®
çŽéãŸãã¯åæéã¢ã«ã³ãã·åºãããšããã·åºã
ã¢ããåºãããã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§
瀺ãããåºïŒåŒäžãR3ã¯åèšãšåãæå³ãè¡šã
ããïŒãè¡šããããã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãã
èªå°äœãåã³R1ãŸãã¯R2ãæ°Žé žåºãè¡šããå Žå
ã«ã¯ããã®éæ¯æ§å¡©ã§ããæ°èŠãªèªå°äœã«é¢ã
ãã äžè¬åŒïŒïŒã«ãããŠãR1åã³R2ã®ãããã
äžæ¹ãæ°Žé žåºãè¡šããå ŽåïŒããªãã¡ãã©ã³ãžã
ã¯ã¢ã·ããäžã«ååšãããµãã€ã®ã«ã«ããã·ã«åº
ã®ãã¡ãããããäžæ¹ã®ã¿ããšã¹ãã«åãŸãã¯ã¢
ããåãããŠããå ŽåïŒã«ã¯ãæ¬çºæååç©ã¯ã©
ã³ãžãã¯ã¢ã·ããã¢ããšã¹ãã«ãŸãã¯ã©ã³ãžãã¯
ã¢ã·ããã¢ãã¢ãããšããŠåœåããããšãã§ã
ããR1åã³R2ã®å®çŸ©ããããããããã«ãã©ã³
ãžãã¯ã¢ã·ããã¢ããšã¹ãã«ãŸãã¯çžåœããã¢ã
ã¢ããã«ã¯ãäžè¬åŒ åã³ ãåŒäžãR1båã³R2bã¯ãççŽ æ°ïŒã12ã®çŽéãŸ
ãã¯åæéã¢ã«ã³ãã·åºãããšããã·åºãã¢ãã
åºãããã¯åŒâNHR3bãŸãã¯âïŒR3bïŒ2ã§ç€ºã
ããåºïŒåŒäžãR3bã¯ççŽ æ°ïŒãïŒã®çŽéãŸãã¯
åæéã¢ã«ãã«åºãè¡šãããïŒãè¡šããããã§ç€ºã
ãããµãã€ã®ã¢ãâ眮æäœãèããããããæ¬çº
æã«ãããŠãç¹å®ã®è¡šç€ºãè¡ãªããåã«ã¢ããšã¹
ãã«ãŸãã¯ã¢ãã¢ãããšããè¡šçŸãçšããå Žåã«
ã¯ãäžè¬åŒïŒïœâïŒïŒã§ç€ºãããååç©åã³äž
è¬åŒïŒïœâïŒïŒã§ç€ºãããååç©åã³ãããã®
æ··åç©ãå«ããã®ãšããã ãŸããäžè¬åŒïŒïŒã«ãããŠãR1åã³R2ããš
ãã«æ°Žé žåºãè¡šãããªãå ŽåïŒããªãã¡ããµãã€
ã®ã«ã«ããã·ã«åºããšãã«ãšã¹ãã«åãŸãã¯ã¢ã
ãåãããŠããå ŽåïŒã«ã¯ãæ¬çºæååç©ã¯ã©ã³
ãžãã¯ã¢ã·ãããã¹ïŒãŸãã¯ãžïŒãšã¹ãã«ãŸãã¯
ã©ã³ãžãã¯ã¢ã·ãããã¹ïŒãŸãã¯ãžïŒã¢ãããšã
ãŠåœä»€ããããšãã§ããã äžè¬åŒïŒïŒã«ãããŠãR1åã³R2ã§è¡šããã
ãççŽ æ°ïŒã12ã®ã¢ã«ã³ãã·åºãšããŠã¯ãã¡ãã
ã·ããšããã·ãããããã·ããããã·ããã³ãã«
ãªãã·ïŒã¢ãã«ãªãã·ïŒãããã·ã«ãªãã·ããã
ãã«ãªãã·ããªã¯ãã«ãªãã·ãããã«ãªãã·ãã
ã·ã«ãªãã·ããŠã³ãã·ã«ãªãã·ãããã·ã«ãªãã·
åºåã³ãããã®ç°æ§äœãæãããããããã®åºã
奜ãŸããã äžè¬åŒ(1)ã«ãããŠãR3åã³R3aã§è¡šããããç
çŽ æ°ïŒã12ã®ã¢ã«ãã«åºãšããŠã¯ãã¡ãã«ããšã
ã«ããããã«ãããã«åºåã³ãããã®ç°æ§äœãæ
ãããããããã®åºã奜ãŸããã äžè¬åŒïŒïŒã«ãããŠR1åã³R2ãè¡šããåºãš
ããŠã¯ãæ°Žé žåºãã¢ã«ã³ãã·åºãããšããã·åºã
ã¢ããåºãåã³åŒâNHR3ãâïŒR3ïŒ2ãâ
NHR3aãŸãã¯âïŒR3aïŒã§ç€ºããããããã®å Ž
åã奜ãŸããã ããã«ãæ¬çºæã«å«ãŸããååç©ãšããŠã¯ãã©
ã³ãžãã¯ã¢ã·ããã®ã¢ã眮æäœïŒã¢ããšã¹ãã«ãŸ
ãã¯ã¢ãã¢ããïŒåã³åãã¹ïŒãŸãã¯ãžïŒçœ®æäœ
ããã¹ïŒãŸãã¯ãžïŒãšã¹ãã«ãŸãã¯ãã¹ïŒãŸãã¯
ãžïŒã¢ãããã®ãããã®å Žåã奜ãŸããã äžè¬åŒ(1)ã§ç€ºãããååç©ã®éæ¯æ§å¡©ãšããŠ
ã¯ãäŸãã°ãããªãŠã ãŸãã¯ã«ãªãŠã ã®åŠãã¢ã«
ã«ãªéå±ã®å¡©ãã«ã«ã·ãŠã åã¯ãã°ãã·ãŠã ã®åŠ
ãã¢ã«ã«ãªåé¡éå±ã®å¡©ãã¢ã³ã¢ããŠã å¡©åã³è¬
åŠçã«èš±å®¹ãããïŒéæ¯æ§ã®ïŒã¢ãã³å¡©ãå«ãŸã
ããã«ã«ãã³é žãšãã®ãããªå¡©ã圢æããé©åœãª
ã¢ãã³ã¯ããç¥ãããŠãããäŸãã°ããã©ã¡ãã«
ã¢ã³ã¢ããŠã ã®åŠãããã©ã¢ã«ãã«ã¢ã³ã¢ããŠã
ã®å¡©ãåã³ã¡ãã«ã¢ãã³å¡©ããžã¡ãã«ã¢ãã³å¡©ã
ã·ã¯ããã³ãã«ã¢ãã³å¡©ããã³ãžã«ã¢ãã³å¡©ãã
ãšããã«ã¢ãã³å¡©ããããªãžã³å¡©ãã¢ããšã¿ããŒ
ã«ã¢ãã³å¡©ããžãšã¿ããŒã«ã¢ãã³å¡©ããªãžã³å¡©ã
ã¢ã«ã®ãã³å¡©ãŸãã¯ïŒ®âã¡ãã«ã°ã«ã«ãã³å¡©çã®
ææ©ã¢ãã³å¡©ãæããããã äžè¬åŒ(1)ã§ç€ºãããæ¬çºæååç©ã¯ããã¹ãŠå ¬
ç¥ã®æ¹æ³ã«ãã補é ããããšãã§ãããããªã
ã¡ãæ§é åŒ ã§ç€ºãããã©ã³ãžãã¯ã¢ã·ãããå ¬ç¥ã®æ¹æ³ã§ãš
ã¹ãã«åãŸãã¯ã¢ããåããããšã«ãã補é ãã
ãããšã¹ãã«ååå¿åã³ã¢ããååå¿ãšããŠã¯çš®
çš®ã®æ¹æ³ãç¥ãããŠããããæ¬çºæååç©ã®è£œé
ã«ãããŠã¯ãã®ã»ãšãã©ã®æ¹æ³ãçšããããšãã§
ãããçš®ã ã®ãšã¹ãã«ååå¿åã³ã¢ããååå¿
ã¯ãããããCalvin A.BuehlerãèããSurvey
of Organic SynthesesïŒvolumeåã³ïŒã
ïŒJohn WileyïŒSonsïŒInc瀟ãã1970幎åã³1977
幎ã«çºè¡ïŒã®Chapter14åã³18ã«è©³ããèšèŒãã
ãŠããã®ã§åç §ããããã ãšã¹ãã«ååå¿ãšããŠã¯ãäŸãã° (1) ã©ã³ãžãã¯ã¢ã·ãããšææã®ã¢ã«ã³ãŒã«ãé ž
觊åªäžã«åå¿ãããæ¹æ³ã (2) ã©ã³ãžãã¯ã¢ã·ãããšææã®ãžã¢ãŸã¢ã«ã«ã³
ãçšããæ¹æ³ã (3) ã©ã³ãžãã¯ã¢ã·ãããé©åœãªæ¹æ³ã«ããé žã
ã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ã«ã³ãŒã«ãšåå¿ãããæ¹æ³ãåã³ (4) ãžã·ã¯ãããã·ã«ã«ã«ããžã€ããïŒä»¥äžã
DCCãšèšãããïŒãŸãã¯ïŒâã¯ããâïŒâã¡ã
ã«ããªãžããŠã ãšãŒãžãïŒä»¥äžãCMPIãšç¥èš
ãããïŒã®ååšäžãã©ã³ãžãã¯ã¢ã·ãããšææ
ã®ã¢ã«ã³ãŒã«ãåå¿ãããæ¹æ³ãçãæããã
ãã (1)æ³ã¯äžæŽ»æ§ææ©æº¶åªãäŸãã°ãã³ãŒã³äžã觊
åªéã®é žãäŸãã°ç¡«é žãå¡©é žãïœâãã«ãšã³ã¹ã«
ãã³é žãäžããåããŠçŽ ã®ååšäžãŸãã¯äžååš
äžãã©ã³ãžãã¯ã¢ã·ãããšææã®ã¢ã«ã³ãŒã«ãåžž
æž©ãŸãã¯å æž©äžã«æ°æéããæ°æ¥éåå¿ãããã
ãšã«ããè¡ãªããããåå¿äžã«çæããæ°Žã¯å ±æ²ž
èžçãã¢ã¬ããŠã©ãŒã·ãŒãã¹ãçšããŠé€å»ããã®
ã奜ãŸãããç®çãšãããšã¹ãã«ã«ãã€ãŠã¯ãæ
æã®ã¢ã«ã³ãŒã«äžã«ã©ã³ãžãã¯ã¢ã·ããã溶解ã
宀枩ã§æ°æ¥éæŸçœ®ããã ãã§ç°¡åã«ãšã¹ãã«åã
é²è¡ããå Žåãããã (2)æ³ã¯ã©ã³ãžãã¯ã¢ã·ãããšææã®ãžã¢ãŸã¢ã«
ã«ã³ãäžæŽ»æ§ææ©æº¶åªãäŸãã°ãžãšãã«ãšãŒã
ã«ãé ¢é žãšãã«ãå¡©åã¡ãã¬ã³ãã¢ã»ãã³äžã宀
æž©ããâ10âã®æž©åºŠã奜ãŸããã¯ïŒâã§åå¿ãã
ãããšã«ããè¡ãªãããã (3)æ³ã¯ã©ã³ãžãã¯ã¢ã·ãããäžæŽ»æ§ææ©æº¶åªã
äŸãã°å¡©åã¡ãã¬ã³ãããã©ããããã©ã³ãïŒ
âãžã¡ãã«ãã«ã ã¢ããäžãã·ãŠãŠé žãžã¯ãã©
ã€ããã¯ããã®é žã€ãœããã«ãŸãã¯ãããã€ã«ã¯
ãã©ã€ãçãçšããŠå®€æž©ããïŒâã§åå¿ãããé ž
ãã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ã«ã³ãŒã«ãšåå¿ãããããšã«ããè¡ãªããããå
å¿ã¯ããªãšãã«ã¢ãã³ãŸãã¯ããªãžã³ã®ããšãå¡©
åºã®ååšäžã«è¡ãªãã®ã奜ãŸããã (4)æ³ã®ãã¡ãDCCãçšããæ¹æ³ã¯ãäžæŽ»æ§æ
æ©æº¶åªãäŸãã°ã¯ãããã«ã ãå¡©åã¡ãã¬ã³äžã
ããªãžã³ã®ããšãå¡©åºã®ååšäžãã©ã³ãžãã¯ã¢ã·
ãããšææã®ã¢ã«ã³ãŒã«ã宀枩ããïŒâã§åå¿ã
ããããšã«ããè¡ãªãããããŸãCMPIãçšãã
æ¹æ³ã¯ãChemistry LettersïŒ1045ïŒ1975ïŒåã³
Bull.Chem.JapanïŒ50ïŒ1863ïŒ1977ïŒã«è©³ããèš
èŒãããŠããããäŸãã°ãäžæŽ»æ§ææ©æº¶åªãäŸã
ã°å¡©åã¡ãã¬ã³ãã¢ã»ãã³ãã¢ã»ããããªã«ãã
ããµã³ããã³ãŒã³ããã«ãšã³äžã奜ãŸããã¯ããª
ãšãã«ã¢ãã³ãããªãžã³ãïŒâãžã¡ãã«ã¢ããã
ãªãžã³ã®ããšãå¡©åºã®ååšäžãã©ã³ãžãã¯ã¢ã·ã
ããšææã®ã¢ã«ã³ãŒã«ãšCMPIã宀枩ãã50âã§
æ°æéåå¿ãããããšã«ããè¡ãªãããã ã¢ããååå¿ãšããŠã¯ãäŸãã° (1) ã©ã³ãžãã¯ã¢ã·ãããé©åœãªæ¹æ³ã«ããé žã
ã©ã€ããŸãã¯æ··åé žç¡æ°Žç©ãšããåŸãææã®ã¢
ãã³ãšåå¿ãããæ¹æ³ãåã³ (2) ã©ã³ãžãã¯ã¢ã·ãããŸãã¯ã©ã³ãžãã¯ã¢ã·ã
ãã®ãšã¹ãã«ãšææã®ã¢ãã³ãåå¿ãããæ¹
æ³ãçãæããããã (1)æ³ã¯ãåèšãããšã¹ãã«åæ³ã®(3)æ³ãšåæ§ã®
æ¹æ³ã§ã©ã³ãžãã¯ã¢ã·ããã®é žãã©ã€ããŸãã¯æ··
åé žç¡æ°Žç©ãžå°ããåŸãææã®ã¢ãã³ãšå®€æž©ã§å
å¿ãããããšã«ããè¡ãªããããåå¿ã¯ããªãšã
ã«ã¢ãã³ãŸãã¯ããªãžã³ã®ããšãå¡©åºã®ååšäžã«
è¡ãªãã®ã奜ãŸããã (2)æ³ã¯ãã¡ã¿ããŒã«ãŸãã¯ãšã¿ããŒã«ã®ãããª
äœçŽã¢ã«ã«ããŒã«äžã奜ãŸããã¯å¡©åã¢ã³ã¢ããŠ
ã ã®ååšäžãã©ã³ãžãã¯ã¢ã·ãããŸãã¯ãã®ãšã¹
ãã«ãšææã®ã¢ãã³ãã50âãã溶åªã®éæµæž©åºŠ
ã§æ°æéåå¿ãããããšã«ããè¡ãªãããã åèšãããšã¹ãã«ååå¿åã³ã¢ããååå¿ã«ã
ããŠã¯ãã©ã³ãžãã¯ã¢ã·ããïŒã¢ã«ã«å¯ŸããŠãæ
æã®ã¢ã«ã³ãŒã«ãŸãã¯ã¢ãã³ã¯0.5ã¢ã«ãã倧é
å°ã奜ãŸããã¯ïŒããïŒã¢ã«çšããããããã®ã
ãã«åŸãããçæç©ã¯ãã¢ã眮æäœãšãã¹ïŒãžïŒ
眮æäœã®æ··åç©ã§ããã®ã§ãå ¬ç¥ã®æ¹æ³ãäŸãã°
åçµæ¶ãããã¯ã·ãªã«ã²ã«ãŸãã¯ã±ã€é žãã°ãã·
ãŠã ãçšããé«é液äœã¯ãããã°ã©ãã€ãèå±€ã¯
ãããã°ã©ãã€ããŸãã¯ã«ã©ã ã¯ãããã°ã©ãã€
çã®æ¹æ³ã«ããåé¢ç²Ÿè£œããããšãã§ããã åºçºåæãšããŠçšããã©ã³ãžãã¯ã¢ã·ããã¯ç¹
éæ60â243020å·æ现æžã«èšèŒãããæ¹æ³ã«ã
ããã©ã³ãžãŠã ãã¡ã¹ãã«ã ãžã€ãã¯ããŒãžãŠãŒ
ã¯çã®æç®ããæœåºåé¢ããããšãã§ãããä»æ¹
ã®åæãšãªãã¢ã«ã³ãŒã«é¡ãŸãã¯ã¢ãã³é¡ã¯å ¬ç¥
ååç©ãããããã¯å ¬ç¥ã®æ¹æ³ã«ãã容æã«è£œé
ãããã äžè¬åŒ(1)ã§ç€ºãããååç©ã®éæ¯æ§å¡©ã¯å ¬ç¥ã®
æ¹æ³ã«ãã補é ãããã ãå¹æã æ¬çºæã®äžè¬åŒïŒïŒã§ç€ºãããã©ã³ãžãã¯ã¢
ã·ããèªå°äœãåã³R1ãŸãã¯R2ãæ°Žé žåºãè¡šã
ãå Žåã«ã¯ããã®éæ¯æ§å¡©ã¯ã5αâãªãã¯ã¿ãŒ
ãŒé»å®³äœçšãæããã®ã§ãåºä¹³åç©ãç¹ã«ããã«
ããã5αâãªãã¯ã¿ãŒãŒã«ãããžããããã¹ã
ã¹ããã³ã®ç£çéå°ã«èµ·å ããçŸæ£ã®æ²»çåã³ïŒ
ãŸãã¯äºé²ã«æçšã§ããããã®ãããªçŸæ£ãšããŠ
ã¯ãäŸãã°ç·æ§åè±æ¯çãã¯ãããšããè±æ¯çã
ã¢ã¯ãåã³åç«è ºè¥å€§çãæããããã æ¬çºæååç©ã®5αâãªãã¯ã¿ãŒãŒé»å®³äœçšã¯ã
以äžã«è¿°ã¹ãã¹ã¯ãªãŒãã³ã°ç³»ã«ãã確èªãã
ãã 5αâãªãã¯ã¿ãŒãŒã«å¯Ÿããé»å®³äœçš (1) å®éšæ¹æ³ J.Shimazakiãã®æ¹æ³ãEndocrinolïŒ
Japon.ïŒ18ïŒ179ïŒ1971ïŒåç §ã®ããšããåèã«
ããŠè¡ãªã€ããããªãã¡éæ§ã©ããã®åç«è ºïŒ
ïœãïŒå容ã®0.25Mã·ãŠç³ãå«ã0.1MHEPES
ïŒPH7.4ïŒã§ãã¢ããžããŒãããåŸé å¿åé¢ãã
ïŒ3000rpmã§10åéïŒãæ²æ®¿ãäžèšç·©è¡æ¶²10mlã«
æžæ¿ããåã³é å¿åé¢ïŒ3000rpmã§ïŒåéïŒã
ãŠåŸãããæ²æž£ã«äžèšç·©è¡æ¶²ïŒmlãå ããŠæžæ¿
ããé µçŽ æº¶æ¶²ãšããã é µçŽ æŽ»æ§ã®æž¬å®ã¯ãïŒâ14Cãâãã¹ãã¹ã
ãã³ïŒ1.5nmolïŒ1.5Ã105cpmïŒãNADPH
ïŒ0.5ÎŒmolïŒãäžèšé µçŽ 溶液ïŒ0.03mlïŒåã³çš®ã
ã®æ¿åºŠïŒ2mMã1mMåã³0.2mMïŒã®æ€äœãå«
ãå šå®¹0.1mlã®åå¿æº¶æ¶²ã37âã§60åéã€ã³ã
ãŠããŒããããé µçŽ åå¿ã¯ã¯ãããã«ã ãšã¡ã¿
ããŒã«ïŒïŒïŒïŒïŒã®æ··å液0.4mlãå ããŠåæ¢
ãããã®åŸé å¿åé¢ïŒ2000rpmã§ïŒåéïŒãã
åŸãããäžæž 50ÎŒãã·ãªã«ã²ã«èå±€ãã¬ãŒã
ã«ã¹ãããããã¯ãããã«ã ãã¡ã¿ããŒã«åã³
é ¢é žïŒ99.2ïŒ0.6ïŒ0.2ïŒã®æ··å液ãçšããŠåé¢
ããããã¬ãŒãããªãŒãã©ãžãªã°ã©ãã€ã«ã
ããçæãããžããããã¹ãã¹ããã³ã®æŸå°æŽ»
æ§ãTLCã¹ãã€ããŒãçšããŠæž¬å®ããé µçŽ æŽ»
æ§é»å®³çãç®åºãããçµæãè¡šïŒã«ç€ºãã (2) çµæ ãè¡šã å®éšçµæãããæ¬çºæååç©ã¯ã5αâãªãã¯
ã¿ãŒãŒé»å®³äœçšãæããããšã確èªããããåŸã€
ãŠãåºä¹³åç©ãç¹ã«ããã«ããã5αâãªãã¯ã¿
ãŒãŒã«ãããžããããã¹ãã¹ããã³ã®ç£çéå°ã«
èµ·å ããçŸæ£ã®æ²»çåã³ïŒãŸãã¯äºé²ã«æçšã§ã
ããããã«ãæ¬çºæååç©ã®æ¯æ§ã¯éåžžã«äœãã
ã®ã§ãããå»è¬åãšããŠååå®å šã«äœ¿çšã§ããã
ãšã確èªãããã æ¬çºæã«å«ãŸããååç©ãäžèšã®ç®çã§çšãã
ã«ã¯ãéåžžå šèº«çïŒäž»ãšããŠåç«è ºè¥å€§çã®æ²»ç
åã³ïŒãŸãã¯äºé²ã®å ŽåïŒãŸãã¯å±æçïŒäž»ãšã
ãŠè±æ¯çåã³ã¢ã¯ãã®æ²»çåã³ïŒãŸãã¯äºé²ã®å Ž
åïŒã«ãçµå£ãŸãã¯éçµå£ã§æäžããããæäžé
ã¯å¹Žä»€ãäœéãçç¶ãæ²»çå¹æãæäžæ¹æ³ãåŠç
æéçã«ããç°ãªãããåç«è ºè¥å€§çã®æ²»çå
ã³ïŒãŸãã¯äºé²ã®å Žåã¯ãéåžžæ人ã²ãšãåœãã
ïŒåã«ïŒmgãïŒïœã奜ãŸããã¯20mgã200mgã®ç¯
å²ã§ïŒæ¥ïŒåããæ°åçµå£æäžããããããŸãã¯
æ人ã²ãšãåœããïŒåã«100ÎŒïœã100mgã奜ãŸã
ãã¯ïŒmgã10mgã®ç¯å²ã§ïŒæ¥ïŒåããæ°åéçµå£
æäžïŒå¥œãŸããã¯éèå æäžïŒããããè±æ¯çå
ã³ã¢ã¯ãã®æ²»çåã³ïŒãŸãã¯äºé²ã®å Žåã¯ãéåžž
æ人ã²ãšãåœããïŒåã«10ÎŒïœã50mgã奜ãŸãã
ã¯100ÎŒïœãïŒmgã®ç¯å²ã§ïŒæ¥ïŒåããæ°åçµç®
æäžãããããã¡ããåèšããããã«æäžéã¯
çš®ã ã®æ¡ä»¶ã§å€åããã®ã§ãäžèšæäžç¯å²ããå°
ãªãéã§ååãªå ŽåããããããŸãç¯å²ãè¶ããŠ
æäžããå¿ èŠã®ããå Žåãããã æ¬çºæã«ããçµå£æäžã®ããã®åºäœçµæç©ãšã
ãŠã¯ãé å€ãæ£å€ãé¡ç²å€çãå«ãŸããããã®ã
ããªåºäœçµæç©ã«ãããŠã¯ãã²ãšã€ãŸãã¯ãã以
äžã®æŽ»æ§ç©è³ªããå°ãªããšãã²ãšã€ã®äžæŽ»æ§ãªåž
éå€ãäŸãã°ä¹³ç³ããã³ãããŒã«ããããŠç³ãã
ãããã·ãããã«ã»ã«ããŒã¹ã埮çµæ¶ã»ã«ããŒ
ã¹ããã³ãã³ãããªããã«ãããªãã³ãã¡ã¿ã±ã€
é žã¢ã«ãã³é žãã°ãã·ãŠã ãšæ··åããããçµæç©
ã¯ãåžžæ³ã«åŸã€ãŠãäžæŽ»æ§ãªåžéå€ä»¥å€ã®æ·»å
å€ãäŸãã°ã¹ãã¢ãªã³é žãã°ãã·ãŠã ã®ãããªæœ€
æ»å€ãç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ã®ãããªåŽ©å£
å€ãå«æããŠããŠããããé å€ãŸãã¯äžžå€ã¯å¿ èŠ
ã«ããçœç³ããŒã©ãã³ãããããã·ãããã«ã»ã«
ããŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ã
ã¿ã¬ãŒããªã©ã®è溶æ§ãããã¯è žæº¶æ§ç©è³ªã®ãã€
ã«ã ã§è¢«èããŠããããããŸãïŒä»¥äžã®å±€ã§è¢«è
ããŠããããããã«ãŒã©ãã³ã®ãããªåžåããã
ãç©è³ªã®ã«ãã»ã«ãå å«ãããã çµå£æäžã®ããã®æ¶²äœçµæç©ã¯ãè¬å€çã«èš±å®¹
ãããä¹³æ¿å€ã溶液å€ãæžæ¿å€ãã·ãããå€ããš
ãªãã·ã«å€çãå«ã¿ãäžè¬çã«çšããããäžæŽ»æ§
ãªåžéå€ãäŸãã°ç²Ÿè£œæ°Žããšã¿ããŒã«ãå«ããã
ã®çµæç©ã¯äžæŽ»æ§ãªåžéå€ä»¥å€ã«æ¹¿æœ€å€ãæžæ¿å€
ã®ãããªè£å©å€ãçå³å€ã颚å³å€ãè³éŠå€ãé²è
å€ãå«æããŠããŠãããã çµå£æäžã®ããã®ãã®ä»ã®çµæç©ãšããŠã¯ãã²
ãšã€ãŸããã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœå ¬
ç¥ã®æ¹æ³ã«ããåŠæ¹ãããã¹ãã¬ãŒå€ãå«ãŸããŠ
ããã æ¬çºæã«ããéçµå£æäžã®ããã®æ³šå°å€ãšããŠ
ã¯ãç¡èã®æ°Žæ§ãŸãã¯éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ã
ä¹³æ¿å€ãå å«ãããæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠ
ã¯äŸãã°æ³šå°çšèžçåã³ççé£å¡©æ°Žãå«ãŸããã
éæ°Žæ§ã®æº¶æ¶²å€ãæžæ¿å€ãšããŠã¯ãäŸãã°ããã
ã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ããªãª
ãŒãæ²¹ã®ãããªæ€ç©æ²¹ããšã¿ããŒã«ã®ãããªã¢ã«
ã³ãŒã«é¡ãããªãœã«ããŒã80çãããããã®ãã
ãªçµæç©ã¯ãããã«é²è å€ã湿最å€ãä¹³åå€ãå
æ£å€ã®ãããªè£å©å€ãå«ãã§ãããããããã¯äŸ
ãã°ãã¯ããªã¢ä¿çãã€ã«ã¿ãŒãéãéã殺è
å€ã®é åãŸãã¯ç §å°ã«ãã€ãŠç¡èåãããããã
ãã¯ãŸãç¡èã®åºäœçµæç©ã補é ãã䜿çšåã«ç¡
èæ°ŽãŸãã¯ç¡èã®æ³šå°çšæº¶åªã«æº¶è§£ããŠäœ¿çšãã
ããšãã§ããã éçµå£æäžã®ããã®ãã®ä»ã®æç©ãšããŠã¯ãã²
ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªãå«ã¿ãããèªäœ
å ¬ç¥ã®æ¹æ³ã«ããåŠæ¹ããããå€çšæ¶²å€ãè»ã³ãŠ
ã®ãããªå¡åžå€ãçŽè¹å æäžã®ããã®åå€åã³è£
å æäžã®ããã®ãããµãªãŒçãå«ãŸããã ç¹ã«è±æ¯çãŸãã¯ã¢ã¯ãã®æ²»çåã³äºé²ã®ãã
ã®çµç®æäžçšã®çµæç©ãšããŠã¯ãããŒã·ãšã³ãã
ããã¯ãã¹ãã¬ãŒã溶液å€ãæžæ¿å€ã乳液ã®ãã
ãªå€çšæ¶²å€åã³è»ã³ãŠãã²ã«ãã¯ãªãŒã ã®ãããª
å¡åžå€ãå«ãŸããããã®ãããªçµæç©ã«ãããŠ
ã¯ãã²ãšã€ãŸãã¯ãã以äžã®æŽ»æ§ç©è³ªããå°ãªã
ãšãã²ãšã€ã®äžæŽ»æ§ãªåžéå€ãäŸãã°èžçæ°Žããš
ã¿ããŒã«ã®ãããªäœçŽã¢ã«ã³ãŒã«ãã»ã¿ããŒã«ã®
ãããªé«çŽã¢ã«ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒ
ã«ããããã¬ã³ã°ãªã³ãŒã«ã®ãããªå€äŸ¡ã¢ã«ã³ãŒ
ã«ãããããã·ãããã«ã»ã«ããŒã¹ã®ãããªã»ã«
ããŒã¹é¡ãåç©æ§åã³æ€ç©æ§ã®èèªãã¯ã»ãªã³ã
ããŠãã·ãªã³ã³ããªãªãŒãæ²¹ã®ãããªæ€ç©æ²¹ãç
é¢æŽ»æ§å€ãé žåäºéçãå«ãããã®çµæç©ã¯äžèš
ã®åžéå€ä»¥å€ã«ãã湿最å€ãæžæ¿å€ãè³éŠå€ãé²
è å€ã®ãããªè£å©å€ãå«ãã§ãããã æ¬çºæã«å«ãŸããäžè¬åŒ(1)ã§ç€ºãããååç©ã®
ãã¡ã奜ãŸãããã®ãšããŠã¯ãäŸãã°ãã©ã³ãžã
ã¯ã¢ã·ããã®ã¢ãã¡ãã«ãšã¹ãã«ãã¢ããšãã«ãš
ã¹ãã«ãã¢ããããã«ãšã¹ãã«ãã¢ãããã«ãšã¹
ãã«ãã¢ãã¢ãããšã¹ãã«ãã¢ãããã·ã«ãšã¹ã
ã«ãã¢ããããã«ãšã¹ãã«ãã¢ããªã¯ãã«ãšã¹ã
ã«ãã¢ãããã«ãšã¹ãã«ãã¢ããã·ã«ãšã¹ãã«ã
ã¢ããŠã³ãã·ã«ãšã¹ãã«ãã¢ãããã·ã«ãšã¹ã
ã«ãã¢ãããšãã«ãšã¹ãã«ãã¢ãã¢ãããã¢ãâ
âã¡ãã«ã¢ãããã¢ãââãšãã«ã¢ãããã¢
ãââãããã«ã¢ãããã¢ãââããã«ã¢ã
ããã¢ãâïŒïŒ®âãžã¡ãã«ã¢ãããã¢ãâïŒ
âãžãšãã«ã¢ãããã¢ãâïŒïŒ®âãžãããã«
ã¢ãããã¢ãâïŒïŒ®âãžããã«ã¢ãããåã³ã
ããã«çžåœãããžïŒåã¯ãã¹ïŒãšã¹ãã«ïŒãã
ãããžã¡ãã«ãšã¹ãã«ã¯é€ããïŒåã³åã¢ããã
åã³ãããã«çžåœããã¢ã«ãã«éšåã®ç°æ§äœãå
ã³ãããã®éæ¯æ§å¡©ãæããããšãã§ããã ãå®æœäŸã 以äžãåèäŸåã³å®æœäŸã«ããæ¬çºæã詳述ã
ãããæ¬çºæã¯ãããã®å®æœäŸã«éå®ããããã®
ã§ã¯ãªãããªãåèäŸåã³å®æœäŸäžã®ãTLCãã
ãNMRãããIRãåã³ãMSãã¯ãåã ãèå±€ã¯ã
ããã°ã©ãã€ãããæ žç£æ°å ±é³Žã¹ãã¯ãã«ãããèµ€å€
åžåã¹ãã¯ãã«ãåã³ã質éåæããè¡šãããã¯
ãããã°ã©ãã€ã«ããåé¢ã®ç®æã«èšèŒãããŠã
ãã«ãã³å ã®æº¶åªã¯äœ¿çšãã溶åºæº¶åªãŸãã¯å±é
溶åªãäœç©æ¯ã§ç€ºããŠãããç¹å¥ã®èšèŒããªãå Ž
åã«ã¯ãIRã¯ã¯ãããã«ã 溶液ã§æž¬å®ããNMR
ã¯éã¯ãããã«ã ïŒCDCl3ïŒæº¶æ¶²ã§æž¬å®ããŠã
ãã çæç©ã®ãã¡ãã¢ããšã¹ãã«ãŸãã¯ã¢ãã¹ã¢ã
ãã¯äžè¬åŒïŒ1bâïŒïŒã§ç€ºãããååç©ãšäžè¬
åŒïŒ1bâïŒïŒã§ç€ºãããååç©ã®æ··åç©ã§ããã å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«åã³å
ãžãšãã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ããïŒïœããšã¿ããŒã«ïŒmlãã
ã³ãŒã³20mlãã¢ãããŠã©ãŒã·ãŒãã¹4A ïŒïœåã³
觊åªéã®ïœâãã«ãšã³ã¹ã«ãã³é žã®æ··åç©ã宀枩
ã§ïŒæ¥éæŸçœ®ããŠåå¿ããããåå¿æ··åç©ãé
ãã液ãæžå§æ¿çž®ãããåŸãããæ®çç©ãã·ãª
ã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšãã«ïŒïœ
âãããµã³ïŒïŒïŒïŒâïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®
ç©æ§æ€ãæããæšé¡ååç©ãã¢ããšãã«ãšã¹ãã«
ïŒç¡è²æ²¹ç¶ïŒ380mgãšãžãšãã«ãšã¹ãã«ïŒçœè²çµ
æ¶ïŒ120mgãåŸãã (a) ã¢ããšãã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.60ïŒ NMRïŒÎŽ5.38ïŒ1HïŒïœïŒã4.96â4.54ïŒ6HïŒ
ïœïŒã4.13åã³4.11ïŒåãããŠ2HïŒåã ïœïŒã
1.80ïŒ3HïŒbsïŒã1.73ïŒ6HïŒbsïŒã1.25ïŒ3HïŒ
ïœïŒã0.93åã³0.91ïŒåãããŠ3HïŒåã ïœïŒã
0.73ïŒ3HïŒïœïŒïŒ IRïŒÎœ2920ã1715ã1625ã1435ã1170ã1110ã
890cm-1ïŒ MSïŒïœïŒe498ã453ã397. (b) ãžãšãã«ãšã¹ãã« èç¹ïŒ44â46.5âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒïŒ
Rf0.35ïŒ NMRïŒÎŽ5.36ïŒ1HïŒïœïŒã4.93â4.55ïŒ6HïŒ
ïœïŒã4.09åã³4.08ïŒåã 2HïŒïœïŒã1.77ïŒ6HïŒ
bsïŒã1.73ïŒbsïŒã1.24ïŒ6HïŒïœïŒã0.92ïŒ3HïŒ
ïœïŒã0.71ïŒ3HïŒïœïŒïŒ IRïŒÎœ2930ã1720ã1630ã1435ã1175ã1110ã
1020ã890cm-1ïŒ MSïŒïœïŒe256ã481ã425. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãã ã¢ãã€ãœãããã«ãšã¹ã
ã«åã³åãžã€ãœãããã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ãã470mgãã€ãœãããããŒã«
120mgãïŒâã¯ããâïŒâã¡ãã«ããªãžããŠã ãš
ãŒãžã383mgãããªãšãšãã«ã¢ãã³ïŒmlã觊åªé
ã®ïŒâãžã¡ãã«ã¢ããããªãžã³åã³å¡©åã¡ãã¬ã³
10mlã®æ··åç©ã宀枩ã§ïŒæéãããŸãããåå¿æ··
åç©ãå¡©åã¡ãã¬ã³30mlã§åžéããåŸãæ°ŽæŽãã
ç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ãããçç©
ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšã
ã«ïŒïœâãããµã³ïŒïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®ç©
æ§å€ãæããæšé¡ååç©ãã¢ãã€ãœãããã«ãšã¹
ãã«ïŒç¡è²æ²¹ç¶ïŒ87mgãšãžã€ãœãããã«ãšã¹ãã«
ïŒç¡è²æ²¹ç¶ïŒ221mgãåŸãã (a) ã¢ãã€ãœãããã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.59ïŒ NMRïŒÎŽ5.37ïŒ1HïŒïœïŒã5.12â4.54ïŒ7HïŒ
ïœïŒã1.75ïŒ3HïŒbsïŒã1.73ïŒ6HïŒbsïŒã1.23
ïŒ6HïŒïœïŒã0.82åã³0.81ïŒåãããŠ3HïŒåã
ïœïŒã0.73åã³0.72ïŒåãããŠ3HïŒåã ïœïŒïŒ IRïŒÎœ2930ã1710ã1630ã1440ã1370ã1280ã
1240ã1170ã1140ã1100ã1040ã890cm-1ïŒ MSïŒïœïŒe512ã453ã439ã397. (b) ãžã€ãœãããã«ãšã¹ãã« TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒïŒ
Rf0.375ïŒ NMRïŒÎŽ5.36ïŒ1HïŒïœïŒã5.04â4.54ïŒ8HïŒ
ïœïŒã1.78ïŒ3HïŒbsïŒã1.74ïŒ6HïŒbsïŒã1.22
ïŒ6HïŒïœïŒã0.84ïŒ3HïŒïœïŒã0.71ïŒ3HïŒïœïŒïŒ IRïŒÎœ2930ã1720ã1440ã1380ã1280ã1170ã
1110ã900cm-1ïŒ MSïŒïœïŒe554ã495ã439. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãããžããšãã«ãšã¹ãã« ã©ã³ãžãã¯ã¢ã·ãã470mgãšã·ãŠãŠé žã¯ããªã
ïŒmlã®æ··åç©ã宀枩ã§30åéãããŸããåŸæžå§æ¿
çž®ããŠãã©ã³ãžãã¯ã¢ã·ããã®é žãã©ã€ããåŸ
ããåŸãããé žãã©ã€ãã«æ°·å·äžãå¡©åã¡ãã¬ã³
ïŒmlã«æº¶ãããããšããŒã«150mgãšããªãžã³0.3ml
ãå ããŠå®€æž©ã§ïŒæéãããŸãããåå¿æ··åç©ã
é ¢é žãšãã«20mlã§åžéããåžå¡©é žåã³æ°Žã§é 次æŽ
æµããç¡æ°Žç¡«é žãããªãŠã ã§ä¹Ÿç¥åŸæžå§æ¿çž®ã
ããæ®çç©ãã·ãªã«ã²ã«ã«ã©ã ã¯ãããã°ã©ãã€
ïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒ10ïŒïŒïŒã§ç²Ÿè£œã
ãŠã次ã®ç©æ§å€ãæããæšé¡ååç©ïŒç¡è²æ²¹ç¶ïŒ
305mgãåŸãã TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.45ïŒ NMRïŒÎŽ7.36â6.92ïŒ10HïŒïœïŒã5.39ïŒ1HïŒ
ïœïŒã4.96â4.60ïŒ6HïŒïœïŒã1.81ïŒ6HïŒbsïŒã
1.76ïŒ3HïŒbsïŒã0.89åã³0.77ïŒåã 3HïŒ
ïœïŒïŒ IRïŒÎœ2950ã1750ã1640ã1600ã1500ã1385ã
1195ã1165ã900cm-1ïŒ MSïŒïœïŒe622ã529ã473ã435. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ãã ã¢ãâïŒïŒ®âãžã¡ãã«
ã¢ããåã³åãã¹âïŒNâ²âãžã¡ãã«ã¢ãã ãã³ãŒã³12mlã«æº¶ãããã©ã³ãžãã¯ã¢ã·ãã
470mgã«ããªãšãã«ã¢ãã³0.7mlã宀枩ã§æ»Žäžã
ãã滎äžçµäºåŸãæ··å液ã«æ°·å·äžã€ãœããã«ã¯ã
ããã«ããŒã0.19mlãå ãã20åéãããŸããŠæ··
åé žç¡æ°Žç©ãåŸããåŸããã溶液ã«40ïŒ ãžã¡ãã«
ã¢ãã³æ°Žæº¶æ¶²ïŒmlãæ°·å·äžã«å ããïŒæéãããŸ
ãããåå¿æ··åç©ã«æ°Žãå ããé ¢é žãšãã«ã§æœåº
ããæœåºæ¶²ãæžå§æ¿çž®ãããæ®çç©ãã·ãªã«ã²ã«
ã«ã©ã ã¯ãããã°ã©ãã€ïŒé ¢é žãšãã«ïŒïœâãã
ãµã³ïŒïŒïŒïŒïŒã§ç²Ÿè£œããŠã次ã®ç©æ§å€ãæãã
æšé¡ååç©ãã¢ããžã¡ãã«ã¢ããïŒçœè²ç²æ«ïŒ93
mgãšãã¹ãžã¡ãã«ã¢ããïŒçœè²ç²æ«ïŒ72mgãåŸ
ãã (a) ã¢ãâïŒïŒ®âãžã¡ãã«ã¢ãã èç¹ïŒ125â135âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.47ïŒ NMRïŒÎŽ5.38ïŒ1HïŒïœïŒã4.98â4.52ïŒ6HïŒ
ïœïŒã3.05åã³3.03ïŒåã 3HïŒïœïŒã1.76ïŒ3HïŒ
bsïŒã1.74ïŒ6HïŒbsïŒã0.82åã³0.73ïŒåã 3HïŒ
ïœïŒïŒ IRïŒÎœ2950ã1720ã1600ã1450ã1410ã1390ã
1350ã900cm-1ïŒ MSïŒïœïŒe497ã424ã388. (b) ãã¹âïŒïŒ®âãžã¡ãã«ã¢ãã èç¹ïŒ132â135âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.27ïŒ NMRïŒÎŽ5.37ïŒ1HïŒïœïŒã4.92â4.54ïŒ6HïŒ
ïœïŒã4.01ã3.96ã3.90åã³3.88ïŒå3HïŒïœïŒã
1.76ïŒ6HïŒbsïŒã1.70ïŒ3HïŒbsïŒã0.84åã³0.73
ïŒåã 3HïŒïœïŒïŒ IRïŒÎœ2950ã1640ã1405ã900cm-1ïŒ MSïŒïœïŒe524ã509ã480ã438ã424ã382. å®æœäŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ãã¢ãã ãšã¿ããŒã«ïŒmlã«æº¶ãããã©ã³ãžãã¯ã¢ã·ãã
ã¢ããšãã«ãšã¹ãã«ïŒå®æœäŸïŒ(a)ã§è£œé ãããïŒ
100mgããªãŒãã¯ã¬ãŒãäžãã¢ã³ã¢ãã¢ã¬ã¹ãå¹
ã蟌ã¿ã100âã§ïŒæéãããŸãããåå¿æ··åç©
ãæžå§æ¿çž®ããåŸãããæ®çç©ãã·ãªã«ã²ã«ã«ã©
ã ã¯ãããã°ã©ãã€ïŒïœâãããµã³ïŒé ¢é žãšã
ã«ïŒé ¢é žïŒïŒïŒïŒïŒtraceéïŒã§ç²Ÿè£œãã次ã®ç©
æ§å€ãæããæšé¡ååç©29mgïŒçœè²ç²æ«ïŒãåŸ
ãã èç¹ïŒ139â141.5âïŒ TLCïŒïœâãããµã³ïŒé ¢é žãšãã«ïŒïŒïŒïŒïŒïŒ
Rf0.41ïŒ NMRïŒÎŽ7.32ã7.00ã6.05åã³5.63ïŒNHïŒåã
ããŠ2HïŒã5.37ïŒ1HïŒïœïŒã4.94â4.54ïŒ6HïŒ
ïœïŒã1.74ïŒ6HïŒbsïŒã1.73ïŒ3HïŒbsïŒã0.79ã
0.78ã0.72åã³0.71ïŒåãããŠ6HïŒåã ïœïŒïŒ IRïŒÎœ2940ã1700ã1640ã900cm-1ïŒ MSïŒïœïŒe469ã397. 以äžãã©ã³ãžãã¯ã¢ã·ãããšãããããïœâã¢
ãã«ã¢ã«ã³ãŒã«ãïœâãã·ã«ã¢ã«ã³ãŒã«ã40ïŒ ã¡
ãã«ã¢ãã³æ°Žæº¶æ¶²åã³ã¢ã³ã¢ãã¢æ°ŽãçšããŠãã
ãããå®æœäŸïŒãïŒãïŒåã³ïŒãšåæ§ã«ããŠãäž
è¡šã«ç€ºãæ¬çºæååç©ãåŸãã ãè¡šã ãè¡šã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
é å€ã®è£œé ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ïŒïœã
ç¹ç¶çŽ ã°ã«ã³ã³é žã«ã«ã·ãŠã ïŒåŽ©å£å€ïŒ200mgã
ã¹ãã¢ãªã³é žãã°ãã·ãŠã ïŒæœ€æ»å€ïŒ100mgåã³
埮çµæ¶ã»ã«ããŒã¹4.7ïœãåžžæ³ã«ããæ··åãæé
ããŠãäžé äžã«50mgã®æŽ»æ§æåãå«æããé å€
100é ãåŸãã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
ããŒã·ãšã³ã®è£œé ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«0.1ïœã
ããããã·ãããã«ã»ã«ããŒã¹ïŒHPCâïŒïŒç»
é²åæšãæ¥æ¬æ¹é補ïŒ1.1ïœåã³éŠææ°æ»Žãåžžæ³
ã«ãã80ïŒ ãšã¿ããŒã«ã«æº¶ãããå šéã100mlãš
ããŠç®çãšããããŒã·ãšã³ãåŸãã 補å€äŸ ïŒ ã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹ãã«ãå«ã
ã¯ãªãŒã å€ã®è£œé ããªãšãã¬ã³ã°ãªã³ãŒã«â400åã³ããªãšãã¬
ã³ã°ãªã³ãŒã«â4000ïŒããããç»é²åæšãæ¥æ¬æ²¹
è補ïŒãããã4.0ïœåã³ã»ã¿ããŒã«0.5ïœã®æ··å
ç©ã80âã«å 枩溶解ããåŸãã©ã³ãžãã¯ã¢ã·ãã
ã¢ããšãã«ãšã¹ãã«0.1ïœãå ããŠåå溶解ãã
ãŠå®€æž©ãŸã§å·åŽãããæ··åç©ã«éŠææ°æ»Žãããã«
粟補氎ãå ããªããååã«ãããŸããŠå šéã10ïœ
ãšããŠç®çãšããã¯ãªãŒã å€ãåŸãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ åŒäžã(i)R1åã³R2ã¯ãããããäžæ¹ãæ°Žé žåº
ãè¡šãããä»æ¹ãççŽ æ°ïŒã12ã®çŽéãŸãã¯åæ
éã¢ã«ã³ãã·åºãããšããã·åºãã¢ããåºããã
ã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§ç€ºãããåºïŒåŒ
äžãR3ã¯ççŽ æ°ïŒãïŒã®çŽéãŸãã¯åæéã¢ã«
ãã«åºãè¡šãããïŒãè¡šãããããããã¯(ii)R1å
ã³R2ã¯ãšãã«åãåºãè¡šãããççŽ æ°ïŒã12ã®
çŽéãŸãã¯åæéã¢ã«ã³ãã·åºãããšããã·åºã
ã¢ããåºãããã¯åŒâNHR3ãŸãã¯âïŒR3ïŒ2ã§
瀺ãããåºïŒåŒäžãR3ã¯åèšãšåãæå³ãè¡šã
ããïŒãè¡šããã ã§ç€ºãããã©ã³ãžãã¯ã¢ã·ããèªå°äœããŸãã¯
R1ãŸãã¯R2ãæ°Žé žåºãè¡šããå Žåã«ã¯ããã®é
æ¯æ§å¡©ã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ããšãã«ãšã¹
ãã«ãŸãã¯çžåœãããžãšãã«ãšã¹ãã«ã§ããç¹èš±
è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãã€ãœããã
ã«ãšã¹ãã«ãŸãã¯çžåœãããžã€ãœãããã«ãšã¹ã
ã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãâïœâã¢ã
ã«ãšã¹ãã«ãŸãã¯çžåœãããžâïœâã¢ãã«ãšã¹ã
ã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãâïœâãã·
ã«ãšã¹ãã«ãŸãã¯çžåœãããžâïœâãã·ã«ãšã¹ã
ã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãããšãã«ãš
ã¹ãã«ãŸãã¯çžåœãããžããšãã«ãšã¹ãã«ã§ãã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãã¢ãããŸã
ã¯çžåœãããžã¢ããã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãââã¡ã
ã«ã¢ãããŸãã¯çžåœãããã¹ââã¡ãã«ã¢ãã
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®èªå°äœã ïŒ ååç©ãã©ã³ãžãã¯ã¢ã·ããã¢ãâïŒïŒ®â
ãžã¡ãã«ã¢ãããŸãã¯çžåœãããã¹âïŒïŒ®âãž
ã¡ãã«ã¢ããã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
èªå°äœã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21204285A JPH0240055B2 (ja) | 1985-09-27 | 1985-09-27 | Ranjitsukuashitsudojudotai |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21204285A JPH0240055B2 (ja) | 1985-09-27 | 1985-09-27 | Ranjitsukuashitsudojudotai |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6272650A JPS6272650A (ja) | 1987-04-03 |
JPH0240055B2 true JPH0240055B2 (ja) | 1990-09-10 |
Family
ID=16615903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21204285A Expired - Lifetime JPH0240055B2 (ja) | 1985-09-27 | 1985-09-27 | Ranjitsukuashitsudojudotai |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0240055B2 (ja) |
-
1985
- 1985-09-27 JP JP21204285A patent/JPH0240055B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS6272650A (ja) | 1987-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0657685B2 (ja) | ïŒÎ±âãªãã¯ã¿ãŒãŒé»å®³æŽ»æ§ãæãããã³ãŸã€ã«ã¢ãããã§ããã·ãã¿ã³é žèªå°äœããããã®è£œé æ¹æ³ããã³ããããå«æããè¬å€ | |
CA2136304A1 (en) | Inhibitors of testosterone 5.alpha.-reductase activity | |
KR20110103471A (ko) | ì ê·í ììŽìœì¬ë žìŽë ì ë첎 | |
KR970006474B1 (ko) | ì ê· "벀조ìŒìë¯žë žíë ¹ìë¶íì° ì ë첎" ë° ê·žì ì ì¡°ë°©ë² | |
KR0135723B1 (ko) | ì ê·í ìì€íë íŽ ì ë첎 ë° ìœí ì¡°ì±ë¬Œ | |
EP0262053A2 (fr) | Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant | |
EP0294937B1 (en) | Novel cinnamoylamide derivatives | |
JPH0240055B2 (ja) | Ranjitsukuashitsudojudotai | |
WO2001060824A1 (fr) | Derives de xanthine, intermediaires et application au traitement de l'osteoporose | |
EP0291247B1 (en) | Novel cinnamoylamide derivatives | |
FR2494697A1 (fr) | Nouveaux derives steroides 3-amines, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant | |
EP0527832A1 (en) | Anti-fungal bile acid derivatives | |
JPH06172287A (ja) | ã¢ããã«ã«ãã³é žèªå°äœåã³è©²ååç©ãå«æããå»è¬çµæç© | |
US5053426A (en) | Simplified thioester and isostere analogs of oleoyl coenzyme a as hypocholesterolemic agents | |
CA1324126C (en) | Stereoisomerically pure 17.alpha.-ethynyl-estra-2-en-17.beta.-ol and the 17.beta.-esters thereof, methods of preparation and uses | |
JPH0741458A (ja) | æ°èŠãªæ¡ç®é žã¢ããèªå°äœããã³ããããå«æããå»è¬å | |
JPH0788339B2 (ja) | æ°èŠãªæ¡ç®é žã¢ããèªå°äœããã³ããããå«æããå»è¬å | |
US5191113A (en) | Cinnamoylamide derivatives | |
JPS62198653A (ja) | ïŒâã¢ããããšããã·ïŒããªïŒã¢ã«ãã«ã«ã«ããã«ã¢ããé žèªå°äœããããã®è£œé æ¹æ³ããã³ãããã®ååç©ãæå¹æåãšããŠå«æããïŒÎ±âãªãã¯ã¿âãŒé»å®³å€ | |
SU1327789A3 (ru) | СпПÑПб пПлÑÑеМО ÑÑеÑПОЎМÑÑ Ð¿ÑПОзвПЎМÑÑ Ñ Ð·Ð°ÐŒÐµÑеММПй 3-аЌОМПгÑÑппПй ОлО ÐžÑ ÐºÐžÑлПÑП-аЎЎОÑОвМÑÑ ÑПлей | |
US5173510A (en) | Simplified thioester and isostere analogs of oleoyl coenzyme A as hypocholesterolemic agents | |
JPH05140062A (ja) | ãã³ãŸã€ã«ã¢ããããšããã·ãã¿ã³é žèªå°äœããã³ããããå«æããè¬å€ | |
EP2694477B1 (fr) | Anilides-alkylthioéthers comme inhibiteurs de l'acat pour le traitement de maladies dermatologiques | |
WO1992001706A1 (fr) | Nouveaux derives de la 6-methyl 19-nor progesterone, substitue en 3 et leur procede d'obtention | |
JPH0662584B2 (ja) | æ°èŠããã³ãã€ã³èªå°äœåã³è©²ååç©ãå«æããè質äœäžå€ |